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EXECUTIVE SUMMARY

In 2016, there were a total of376 drug-induced 1 deaths in Maine, which is more than one death a
day. Deaths from opioids account for 313 of those deaths. Because of the urgency of the opioid
crisis, the Task Force to Address the Opioid Crisis in the State was created by the First Regular
Session of the 128th Maine State Legislature by Joint Order, S.P. 210. The Opioid Task Force
(the "task force") was established to "examine the cmTent laws in the State addressing opiate
abuse and heroin use, including, but not limited to, existing laws focused on law enforcement,
prevention, treatment and recovery." The task force was further tasked with the following
specific responsibilities:
•
•
•

Review the 2016 report and recommendations of the Maine Opiate Collaborative
(MOC);
Review initiatives undertaken by other states, with particular attention to proposals
regarding opioid treatment, enforcement and prevention; and
Develop recommendations to address Maine's opioid crisis.

The members of the task force were appointed by late March of 2017 and were required by the
Joint Order to submit an initial report to the Legislature by April 30, 2017, which was submitted
in Apri I and revised in May 2017. The task force was also required to submit a final report with
any recommendations and suggested legislation to the Legislature by December 6, 2017. The
task force met ten times and finalized its recommendations at the November 28 meeting. As part
of its deliberations, the task force divided into small groups to consider prevention/harm
reduction, treatment/recovery and law enforcement.
The task force recognized that the final recommendations to address the opioid crisis needed to
take an integrated and comprehensive approach. The recommendations are broken into three
categories to reflect the work of the small groups and the approach of the MOC. However, in
developing the recommendations, the task force did not lose sight of how the categories are
interrelated.
The task force presents the following unanimous recommendations. The Executive Branch
participated in the task force by providing information and collaborating with members but did
not take any positions on pa1ticular recommendations or legislation.
Prevention and Harm Reduction Recommendations

The task force considers prevention and harm reduction a critical piece of addressing the opioid
crisis. It is more efficient to prevent problems before they begin. Harm reduction minimizes the
negative impact of the problem.
1. Request by letter that Maine Department of Health and Human Services report to the
Joint Standing Committee on Health and Human Services by March 1, 2018 on the
1
"A "drug-induced death" is identified when one or more drngs are mentioned on the death certificate as a
cause or significant contributing factor for the death." See
http://www.mainehealthindex.org/sites/default/fi les/Drug%20Death%202016%20Final%20Rpt%20April%2011 %20
2017.pdf

dissemination to providers of the updated Snuggle J'v1E curriculum and other
evidence-based programs and recommend expansion of Positive Parenting Program to
parents and families who would benefit. (Appendix H.)
2. Request by letter that medical provider organizations communicate the imp01tance of
counseling patients on the importance of and availability of long-acting reversible
contraception, including coverage under MaineCare. (Appendix I.)
3. The Joint Standing Committee on Education and Cultural Affairs consider introducing
legislation directing the Depa1tment of Education to establish a work group to evaluate
existing drug prevention programs targeting school-age children and how to incorporate
those programs into educational curriculum. The work group should include the Maine
Education Association, Maine School Management Association, Maine Principals
Association, Maine Interscholastic Athletic Administrators Association and
representatives of law enforcement and organizations that promote and facilitate
programs relating to public health, drug prevention and the welfare of children.
(Appendix J.)
4. The Joint Standing Committee on Health and Human Services consider introducing
legislation directing the Office of the Revisor of Statutes to update the statutes to reflect
current te1minology relating to substance use disorders. (Appendix K.)
5. Promote programs that take back prescription drugs but do not create a consumer-borne
cost for that program. Request by letter that Maine Dmg Enforcement Administration
report to the Joint Standing Committee on Criminal Justice and Public Safety by March
1, 2018 about the successes of the drug take-back programs; publicity of the collection
days; the use of alternative drug disposal options, such as Deterra; and expanded
placement of take-back units in appropriate law enforcement or other secure facilities.
(Appendix L.) Request by letter to the Maine Board of Pharmacy that it require
pharmacies to place a notice in an obvious place informing patients about disposing of
excess medication. (Appendix M.)

Treatment and Recovery Recommendations
The task force spent a considerable amount of time considering treatment options because more
than one person a day dies from a drug overdose. Treatment is therefore critical to addressing
the immediate needs of the crisis.
6. Request by letter to the Department of Health and Human Services to examine how the
opioid health home model under the current Centers for Medicare and MaineCare
Services waiver could integrate evidence-based treatments, such as the hub and spoke
model in LD 1430, an Act To Develop a Statewide Resource and Referral Center and
Develop Hub-and-spoke Models To Improve Access, Treatment and Recovery for Those
with Substance Use Disorder, which was carried over to any Special or Regular Session
of the 128th Legislature. Fund a continuum of evidence-based services of differing
intensities that meet the treatment needs of individuals depending upon stage of recovery,

ii

including integrated medication-assisted treatment across the state and integrated
community-based relationships. (Appendix 0.)
7. The Joint Standing Committee on Health and Human Services consider introducing
legislation, such as LD 605, An Act To Support Evidence-based Treatment for Opioid
Use Disorder, that immediately increases access to treatment across the state for patients,
including those who lack insurance or the means to pay, by increasing grant funds
available to evidence-based programs that provide treatment to patients at varying levels
of acuity. Request by letter that the Department of Health and Human Services, within
existing financial resources, immediately increase access to treatment across the state for
patients, including those who lack insurance or the means to pay, by increasing grant
funds available to evidence-based programs that provide treatment to patients at varying
levels of acuity. Request that the Department of Health and Human Services consider
allowing minimum security offenders in custody or people in community release
programs to access treatment slots for the uninsured. (Appendix P .)
8. Increase access to treatment across the state by increasing access to health insurance
coverage. Write a letter to the Legislative Council to support the introduction of LR
2755, An Act Regarding Health Care Ombudsman Services, in the Second Regular
Session. LR 2755 would assist people with accessing health insurance. (Appendix Q.
The appeal to the Legislative Council was successful and the bill was approved for
introduction.)
9. Request by letter to the congressional delegation, U.S. DHHS, SAMHSA and CMS that
the federal government amend 42 CFR Part 2 and the related federal statute to allow for
greater information sharing between providers regarding medication-assisted treatment
and treatment of substance use disorders. (Appendix R.)
10. Support the development of recovery housing that meets the standards of the Maine
Association of Recovery Residences to serve people in recovery, including those who are
engaged in integrated medication-assisted treatment. Request by letter that Maine State
Housing Authority convene a work group to develop a certification process for recovery
housing and investigate available funding resources and development opportunities and
to report quarterly to the Joint Standing Committees on Labor, Commerce, Research and
Economic Development and Health and Human Services for one year, beginning March
1, 2018. The work group should include Maine's Department of Health and Human
Services, Finance Authority of Maine, Maine Real Estate and Development Association,
the Maine Association of Recovery Residences and representatives of treatment
providers, housing services, affordable housing developers, the recovery community and
persons experiencing homelessness. (Appendix S.)
11. Write a letter to the Legislative Council to support the introduction of two bill requests in
the Second Regular Session dealing with recovery housing that are on appeal: LR 2744,
An Act to Save Lives and Create the Homeless Opioid User Service Engagement Pilot
Project and LR 2521, An Act to Ensure Quality of and Increase Access to Recovery
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Residences. (Appendix Q. The appeals to the Legislative Council for LR 2744 and
LR 2521 were successful and the bills were approved for introduction.)
12. Request by letter to Maine Department of Health and Human Services that the
department evaluate the options for developing a database of available treatment services,
including what information the database would contain; whether it could include
real-time data and the usefulness of that data; how to accurately identify provider
capacity and waitlists; how much it could cost; and how it could be implemented and
funded. The department shall report back to the Joint Standing Committee on Health and
Human Services by March 1, 2018. (Appendix T.)
13. Request by letter to the 2-1-1 program of United Way of Mid-Maine that it report by
March 1, 2018 to the Joint Standing Committee on Health and Human Services regarding
ongoing improvements to the 2-1-1 service in relation to substance use disorders,
including the accuracy and ease of accessibility of the website and database; staff
training; outreach to providers who are not licensed by the State; and plans for increasing
public awareness of 2-1-1 services, including alternative platforms to access information.
(Appendix U.)
Law Enforcement Recommendations
The intersection between the criminal justice system and mental illness, substance use disorders
or co-occurring disorders is well known. These recommendations address several aspects of the
criminal justice system.
14. Develop and fund pre-charge diversion programs at the municipal, county and state
levels. The programs should be developed in consultation with prosecutors, law
enforcement and other stakeholders. The programs should minimize a person's contact
with the criminal justice system by connecting them with treatment and recovery
services, including case management, at the appropriate level based on an assessment
process. Because implementing this recommendation requires the cooperation of the
criminal justice and treatment communities, the Joint Standing Committees on Health and
Human Services, Criminal Justice and Public Safety and Judiciary should collaborate to
develop the programs.
15. The Joint Standing Committee on Judiciary consider introducing legislation that develops
additional drug courts or increases access to existing drug courts across the state and
provides the necessary funding.
16. The Joint Standing Committee on Criminal Justice and Public Safety consider
introducing legislation that develops and funds assessments and services in jails upon
intake for mental health and substance use disorders, including integrated medicationassisted treatment.
17. The Joint Standing Committee on Criminal Justice and Public Safety consider
introducing legislation that develops and funds assessment and services for people in jails
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and prisons for mental health and substance use disorders, including integrated
medication-assisted treatment and access to hub and spoke services in the community, for
people serving their sentences.
18. The Joint Standing Committee on Criminal Justice and Public Safety consider
introducing legislation that develops and funds programs that prepare inmates for their
release into the community, including connections with integrated medication-assisted
treatment and access to hub and spoke services in the community. These programs
should include family members or other supportive people in the inmate's life so they can
be natural supports during reintegration.
19. The Joint Standing Committee on Criminal Justice and Public Safety consider
introducing legislation that enacts an advisory board to advise the Depa11ment of
Corrections and county or regional jails on the treatment programs and rehabilitation
needs of the facility populations. The advisory board will evaluate on an ongoing basis
existing services and evidence-based practices for managing the needs of offenders and
pretrial defendants and recommend the implementation of appropriate programs.
(Appendix W.)
20. Write a letter to the Joint Standing Committee on Appropriations and Financial Affairs
expressing support for Sections 1 and 4 ofLD 1429, An Act Regarding the Epidemic of
Opiate Abuse, which has been carried over on the appropriations table. (Appendix X.)

V

I.

BACKGROUND

The Opioid Crisis in Maine
The Opioid Task Force was established to deal with the burgeoning opioid crisis in the State of
Maine. The membership of the task force reflects a broad diversity of experience with the opioid
crisis, including legislators, providers of treatment services and recovery services, law
enforcement and persons with recovery experience. The opioid crisis affects people from all
walks of life, including every socioeconomic class, profession, gender, age group and ethnicity.
The victims of the crisis reflect a broad cross-section of society. Because of that, the effects of
the opioid crisis are far-reaching and have ripple effects on families, employers, the criminal
justice system, child welfare, medical costs and a myriad of other facets of life.
There are a number of causes of the opioid crisis that have been explored, including
over-prescribing of opioids, traumatic events, social isolation and Adverse Childhood
Experiences (ACEs). Over-prescribing practices have been curtailed and this is described below.
The task force believes that ACEs, in particular, are of tremendous significance in the growth
and depth of the opioid crisis. Investing in the safety and wellbeing of children to reduce the
number of adverse experiences would be an effective long-term prevention strategy. However,
there is no single solution to the ACEs problem. Addressing this issue is complex and would
have required the task force to exceed the scope of its expertise. Consequently, the task force
focused on recommendations that could be accomplished in the short term.
The statistics about the extent of the crisis in Maine are alarming. According to data contained in
a report commissioned by the Maine Attorney General titled, "Expanded Maine Drug Death
Report for 2016:"

•
•
•
•
•
•
•
•

In 2016, there were a total of 376 drug-induced deaths in Maine; this number represents
an increase of 104 deaths, which is a 38% increase from 2015;
Of the 376 overdose deaths, 330 (88%) were accidental overdoses, 38 (10%) were
suicides and 8 (2%) were of an undetermined nature;
79% of overdose deaths in 2016 were caused by two or more drugs;
84% of the overdose deaths were caused by at least one opioid, including pharmaceutical
and illicit opioid drugs;
63% of the overdose deaths were attributable to either fentanyl and/or heroin/morphine;
16% of the overdose deaths were attributable to cocaine, an increase by 71 % since 2015;
Deaths attributable to pharmaceutical opioids have remained relatively stable at 33% of
the total; and
The average age of overdose deaths in Maine for 2016 was 41. Males outnumber females
by 2 to 1.

Between January and June of 2017, the Attorney General reported that there were 185 deaths
attributable to drug overdose. Of those drug overdose deaths, 61 % were caused by fentanyl and
30% were caused by pharmaceutical opioids. In a little over one-third of opioid deaths, the
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victims were treated with naloxone. In 2016, 25% of persons who died from an overdose
received were treated with naloxone. 2
The State Epidemiological Outcomes Workgroups Report, Substance Abuse Trends in Maine,
State Epidemiological Profile 2017, identified basic statistics for treatment for people with
substance use disorders:
•

•

•

In 2013-14, young adults aged 18 to 25 years were the most likely age group to need but
not receive treatment for drugs or alcohol. About one in eight 18 to 25 year olds in
Maine needed but did not receive treatment for alcohol use and nearly one in ten needed
but did not receive treatment for illicit drug use;
In 2016, a little more than one in three substance use treatment admissions listed alcohol
as the primary reason for treatment, following by heroin/morphine and other
opiates/synthetics. 58% of the primary admissions were related to opioids. Primary
admission rates related to heroin/morphine have steadily increased since 2012 and have
surpassed synthetic opiates as the second most common substance; and
Of the admissions that listed a secondary substance, nearly one in three was related to
marijuana and one in four was related to synthetic opiates. Rates related to synthetic
opiates have steadily decreased while rates involving heroin/morphine have progressively
increased.

Creation of the Opioid Task Force
Because of the urgency of the opioid crisis, the Task Force to Address the Opioid Crisis in the
State was created by the First Regular Session of the 128th Maine Legislature by Joint Order,
S.P. 210 (Appendix A). The Opioid Task Force (the "task force") was established to "examine
the current laws in the State addressing opiate abuse and heroin use, including but not limited to
existing laws focused on law enforcement, prevention, treatment and recovery." The task force
was further tasked with the following specific responsibilities:
•
•
•

Review the 2016 report and recommendations of the Maine Opiate Collaborative
(MOC);
Review initiatives undertaken by other states, with particular attention to proposals
regarding opioid treatment, enforcement and prevention; and
Develop recommendations to address Maine's opioid crisis.

The members of the task force (Appendix B) were appointed by late March 2017 3 and were
required by the Joint Order to submit an initial report to the Legislature by April 30, 2017, which
was submitted in April and revised in May 2017. The task force was also required to submit a
final report with any recommendations and suggested legislation to the Legislature by December
6, 2017. The task force finalized its recommendations at the November 28 meeting.
2

See http://wwv. .maine.gov/ag/news/article.shtml?id=76546l
1

3
Dr. Christopher Pezzullo, Chief Health Officer with the Department of Health and Human Services (DHHS),
joined the task force beginning with the September 12, 2017 meeting. The Executive Branch participated in the task
force by providing information and collaborating with members but does not take any positions on particular
recommendations or legislation.
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Opioid Task Force approach and process
The task force met ten times between April and November 2017. The purpose of the task force's
first two meetings was to obtain a broad overview of the scale and factors of the opioid epidemic
in Maine. The task force intended to use the information gathered in these first two meetings as
a basis for beginning to learn about the various aspects of the opioid crisis and receive an
overview of the cun-ent status of the opioid epidemic in Maine by:
• Discerning the gaps in the current efforts to stem the opioid crisis;
• Identifying which programming efforts currently exist, including those in other states;
•
•

Identifying which programs are proving to be effective; and
Determining recommendations for laws and initiatives necessary to stem the opioid crisis
in Maine.

The task force took the approach that addiction/substance use disorder is a chronic disease
similar to diabetes, high blood pressure or asthma. At the first meeting, task force member
Dr. Vernon Gardner provided a briefing on the brain chemistry of opioid addiction. He stated
that, "[a]ddiction is a primary disease of brain circuits that affects emotions, memory, motivation
and reward leading to biological, psychological, social and spiritual symptoms." Addiction is
influenced by both biological genetic factors that affect a person's vulnerability to addiction and
environmental factors, such as adverse childhood experiences (ACEs). Dr. Gardner also stated
that marginalization and criminalization are not effective in reducing addiction. In separate
materials distributed to the task force from a presentation to the Joint Standing Committee on
Health and Human Services, Dr. Jonathan Fellers explained that addiction alters the brain so that
the individual's ability to exert self-control is seriously impaired. Individuals with substance use
disorders may relapse several times before recovery. Because of the medical basis of substance
use disorders, research has demonstrated that integrated medication-assisted treatment (IMAT),
4
which combines medication with behavioral supports, is the best practice.
The task force's recommendations build on the process and progress of the MOC. The MOC
was a coalition formed after a summit held by Governor LePage in August 2015 to address the
opioid epidemic in the State. It was led by Thomas Delahanty, U.S. Attorney; Janet Mills,
Attorney General; and Commissioner John Morris of the Department of Public Safety. The
collaborative was organized into three groups focusing on (1) law enforcement, (2) prevention
and harm reduction and (3) treatment. The MOC began its work in October 2015 and held
multiple meetings and more than 20 public forums around the state. It issued its final report on
May 6, 2016, which is available here: https://wwwl.maine.gov/ag/docs/20160513084630118.pdf.
The task force recognized that the final recommendations to address the opioid crisis needed to
take an integrated and comprehensive approach. Many of the areas implicated in addressing the
opioid crisis - the criminal justice system, availability of treatment services and public
education, for example - are interrelated and interdependent and require a coordinated system.
However, in order for the task force to be able to evaluate and develop recommendations in a
manageable way and honor the work of the MOC, it decided to divide into three small groups 4
When this report identifies data provided by DHHS that references medication-assisted treatment (MAT), it is
not an indication that the actual services being provided do not include behavioral supports.
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prevention/harm reduction, treatment/recovery and law enforcement. The task force did not Jose
sight of how the small groups are interrelated. The small groups frequently identified in its
meetings how many recommendations could fall into multiple small groups and were conscious
of not creating "silos."
The small groups began their discussions by reviewing the final recommendations of the MOC.
The sma11 groups reviewed which of those recommendations had already been accomplished and
with regard to which legislative action is no longer necessary. The small groups also evaluated
each of the MOC recommendations for ease and impact. Carol Kelly of Pivot Point, Inc., as a
consultant for the Maine Medical Association, led the small groups through the matrix she
developed to assess recommendations based on how easy they would be to implement and how
great an impact they would have. The small groups used this exercise as a starting point to begin
discussing recommendations in more detail and to determine where there was consensus among
the members. The small groups also identified additional ideas for recommendations. The small
groups met over the course of two meetings and reported back their recommendations to the full
task force.
The task force reconvened as a whole group to receive the report backs from the small groups
and continue their evaluation and discussion of which recommendations to put forward as a
group. The task force used informal voting methods to identify the recommendations with the
most support from the members.
During this time, the task force also received detailed information from the Department of Health
and Human Services ("DHHS" or "the depattment") through task force member Dr. Christopher
Pezzullo. The task force engaged in a constructive dialogue with Dr. Pezzullo on understanding
the efforts of the department to address the opioid crisis, understanding the data presented and
any limitations of that data, feedback on accessing department programs and identifying areas
where there could be collaboration. The task force also received a few additional presentations
on background information as they decided on their final recommendations.
In order for the task force to make recommendations for the future, it identified existing
legislation that addressed some of the recommendations of the MOC and gathered information
about current activities of the Executive Branch relating to substance use disorders. 5
In State Fiscal Year (SFY) 2017, the Office ofMaineCare Services within DHHS spent over $20
million for medication-assisted treatment (MAT) and the Office of Substance Abuse and Mental
Health Services (SAMHS) spent $880,000. In SFY 18, SAMHS has a $5.5 million MAT budget,
including $2 million for opioid health homes (OHHs). OHHs are based on an integrated care
delivery model, including substance use disorders counseling, care coordination, MAT, peer
support and recovery coaching and medical consultation. OHHs were based on the behavioral
health home (BHH) model, which also integrated physical and behavioral health services. Both
BHHs and OHHs are reimbursed with a bundled rate rather than fee-for-service. In the spring of
2017, the Legislature authorized funding in a supplemental budget for the creation of OHHs to
provide services to MaineCare members and the uninsured. The first OHH provider was
approved by the end of April. As of September 2017, five OHHs had been approved with eight
5

Please see Appendix C for the narrative provided by DHHS outlining its efforts to address the opioid crisis.
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distinct sites and 15 applications in process. The first OHH to begin serving MaineCare
members is in Calais and was anticipated to begin offering services in October 2017. Other
approved providers include two methadone clinics and one Federally Qualified Health Center.
(See Appendix D for DHHS's presentation on OHHs received by the task force.)
In an effo1t to understand the number of individuals cmTently receiving MAT, the task force
requested information from the department and from the Maine Health Data Organization
(MHDO). Because there is no single of source for data, the task force received a variety of data
in an attempt to try to answer the question of the number of individuals in treatment:
•

The department stated that as of September 18, 2017 there were 3,872 individuals in
methadone treatment, 5,172 participants in buprenorphine (suboxone) treatment and 46
individuals in naltrexone treatment. This data represents a moment in time. (See
Appendix E.)

•

The MHDO provided a preliminary analysis of pharmacy and medical claims paid by
commercial insurance in 2016. Different insurance companies use different medical
codes to describe similar procedures and pharmaceuticals, making an exact count of
individuals, prescriptions and costs very difficult. MHDO identified 2,412 pharmacy
claims for buprenorphine/naloxone and 1,718 pharmacy claims for suboxone in 2016.
MHDO stated that 739 members were covered for naltrexone and 525 for methadone.
For medical claims, 65 members received inpatient detoxification and four received
outpatient detoxification. 410 received outpatient substance use disorders treatment and
313 were covered for methadone treatment. (See Appendix F).

•

Buprenorphine prescribing is entered into the Prescription Monitoring Program (PMP),
which gives an indication of the actual number of prescribers, total patients and total
prescriptions. In 2016, 892 prescribers treated 15,294 patients and prescribed 190,576
prescriptions. Between January 1, 2017 and September 30, 2017, 1,091 prescribers
treated 15,064 patients and prescribed 178,765 buprenorphine prescriptions. (See
Appendix G.) More physicians are qualified to prescribe buprenorphine through a Drug
Enforcement Administration (DEA) waiver than actually prescribe. Knowing the number
of physicians along with the number of patients the physician could manage does not give
an accurate indication of the number of slots available for buprenorphine treatment for
individuals with substance use disorders.

The task force also attempted to quantify the treatment capacity in the state, including the
numbers of licensed residential treatment beds, intensive outpatient slots, detoxification beds and
the length of waitlists. As will be discussed in the recommendations later, some members of the
task force believe that the ability to quantify treatment capacity will help people access treatment
services.
In addition to the actions of the Executive Branch, the Legislature has also taken a number of
steps to address the opioid crisis. A number of task force members reiterated the importance of
laws limiting the prescribing of opioid prescriptions. Public Law 2015, chapter 488, Public Law
2017, chapter 213 and Resolve 2017, chapter 16 enacted a new statutory and regulatory
framework for opioid prescribing. The new laws limit opioid prescriptions to seven days for
Opioid Crisis in the State Final Report 5

acute pain and 30 days for chronic pain, as well as limiting new prescriptions to no more than
100 morphine milligram equivalents, with exceptions for surgery, cancer treatment and after
care, palliative care and direct administration by health professionals in emergency rooms and
nursing facilities. The laws also mandate the use of the PMP by prescribers and phatmacists in
most prescribing circumstances. The limits imposed by the laws are intended to limit the supply
of opioids available for diversion as well as recognize current treatment best practices for acute
and chronic pain (including the CDC guidelines published in early 2016 6).
Task force members recognize the importance of alternative treatments such as physical therapy,
acupuncture, meditation and neurofeedback to address chronic pain, and recognize that access to
these types of alternative treatments could also reduce the use of opioids. The Legislature has
taken steps to expand availability of some alternative treatments for substance use disorders.
Public Law 2017, chapter 185 establishes a cost-neutral pilot project within the MaineCare
program to treat substance use disorders with acupuncture. In addition, the Joint Standing
Committee on Insurance and Financial Services carried over LD 453, Resolve, Regarding
Insurance Coverage for Alternative Therapies for Addiction and Recovery. LD 453 requires the
Superintendent of Insurance to convene interested parties to evaluate commercial insurance
coverage for substance use disorders treatment and recovery alternatives.
The Legislature increased the availability of naloxone. Public Law 2015, chapter 508 directed
the Maine Board of Pharmacy to establish procedures and standards for authorizing pharmacists
to dispense naloxone by prescription drug order or standing order pursuant to a collaborative
practice agreement. The law was amended in Public Law 2017, chapter 249 to require
rulemaking to allow pharmacists to dispense naloxone over-the-counter to individuals at risk of
an overdose or to friends or family members of an individual at risk of an overdose (this section
of law sunsets on July 1, 2019). At the time of writing this report, the rules were in process and
not yet adopted. Similarly, Public Law 2015, chapter 351 allowed community-based drug
overdose prevention programs to obtain naloxone through standing orders and administer it to
individuals who appear to be experiencing an opioid-related drug overdose. DI-Il-IS is currently
in the process of adopting mies to implement this legislation. Task force members reiterated at
several meetings the importance of these pharmacy and community organization rules. In
addition, Public Law 2017, chapter 220 allowed state, county and regional cmrections officers to
administer naloxone. Jails were previously unable to have naloxone available if an individual
who had recently been arrested and entered the jail experienced an overdose.
In line with MOC recommendations, the Legislature enacted Public Law 2017, chapter 265 to
allow for credits from coursework in addiction counseling at an accredited college or university
to count towards clinical practice hours requirements for licensure as a drug and alcohol
counselor. The law also requires MaineCare to reimburse a licensed clinical professional
counselor at the same rate as a licensed clinical social worker. It reduces the requirements for
continuing professional education and increases the number of distance learning hours that
qualify as a continuing education activity. MOC recommendations were aimed at increasing the
supply of treatment providers for substance use disorders.

6

See https://www.cdc.gov/mmwr/volumes/65/rr/rr6501 el .htm for CDC guidelines.
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II.

SUMMARY OF MEETINGS

The task force held ten meetings on the following dates in 2017: April 7, April 21, June 9, July
12, August 16, September 12, September 27, October 31, November 13 and November 28. The
task force will be holding one additional meeting on December 12, 2017, to strategize the
presentation of its report to the Second Regular Session of the 128th Legislature, but will not be
making any substantive changes to its recommendations.
The meetings of the task force are briefly summarized here. 7 Any documents distributed to the
task force at the meetings are posted on the task force website:
http://www.maine.gov/legis/opla/OpioidTaskForce.htm.

1. April 7, 2017: The task force received the following presentations:
a. Task force member Dr. Vernon Gardner made a brief presentation regarding the brain
chemistry of opioid addiction.
b. Members of the MOC presented its recommendations. Co-Chairs Sheriff Joel Merry
(Sagadahoc County) and Portland Chief of Police Michael Sauschuk presented the
recommendations from the prevention/harm reduction task group. Eric Haram,
LADC presented the recommendations of the treatment task force. Co-Chair Scott
Gagnon, MPP, PS-C, Substance Abuse Prevention Manager for Healthy
Androscoggin presented the recommendations from the law enforcement task force.
c. Spreadsheets compiled by contract staff containing pending opioid-related legislation
in Maine and a partial list of other state's programs and national programs in response
to the opioid crisis.

2. April 21, 2017: The task force received the following presentations:
a. Dr. Mary Dowd, Medical Director of the Milestone Foundation, presented on
detoxification services.
b. Task force member Malory Shaughnessy, Executive Director of the Alliance for
Addiction and Mental Health Services, presented on OHHs.
c. Sara Bachelder, LADC, CCS, Clinical Team Leader of Milestone's Extended Care
Program, presented on residential treatment services.
d. Peter McCorison, Behavioral Health Services Director, Aroostook Mental Health
Center, presented on intensive outpatient and outpatient treatment.
e. Anne Jordan, Esq., Manager of Criminal Process and Specialty Dockets, State of
Maine Judicial Branch, presented on drug comis in Maine.

7

For more detailed descriptions of the task force's April meetings, please refer to the task force's Interim
Report.
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3. June 9, 2017: The task force received the following presentations:
a. Tom Kivler, LCPC, CCS, Director of Behavioral Health, Addiction Resource Center
(ARC), Mid Coast Hospital, presented on ARC's program.
b. Robbie Moulton, Scarborough Chief of Police, presented on Operation HOPE.
c. Scott Gagnon, MPP, PS-C, Sally Mannient and Liz Blackwell-Moore, Drug Free
Communities, presented on Drug Free Communities' program model.
For the next meeting, members of the task force were directed to identify the top three
barriers to addressing the opioid crisis.

4. July 12, 2017: The task force received the following presentations:
a. Senator Eric Brakey and Representative Patricia Hymanson, Chairs of the Health and
Human Services Committee, presented on opioid-related legislation proposed in the
First Regular Session of the 128th Legislature.
b. Representative Charlotte Warren, Chair of the Criminal Justice and Public Safety
Committee, presented on opioid-related legislation proposed in the First Regular
Session of the 128th Legislature. Senator Kimberly Rosen, Chair of the Criminal
Justice and Public Safety Committee, was invited but was unable to attend.
c. Task force members Justice William Stokes and Representative Pinny Beebe-Center
presented a flow chart depicting the effect of substance abuse violations on the
judicial process.
Task force Co-Chair Representative Joyce "Jay" McCreight led the task force in a compilation of
and discussion of the barriers identified by task force members. The task force decided to break
into small groups on prevention/harm reduction, treatment/recovery and law enforcement for the
next meeting. Before the next meeting the task force members were directed to evaluate the
recommendations of the MOC for relative ease and impact.

5. August 16, 2017: The prevention/harm reduction small group met first for two hours,
followed by the treatment/recovery and law enforcement small groups. Each small group
received a brief presentation from Carol Kelly on understanding the matrix she created
with the results of the members' evaluation of the recommendations of the MOC for ease
and impact. Each small group then moved into their discussions of the MOC
recommendations, including additional brainstorming of recommendations and
discussions of barriers affecting the recommendations. The prevention/harm reduction
small group tasked its members with finding out more information on certain topics
before the next meeting. The treatment/recovery small group heard from Pat Kimball,
former director of Wellspring, on issues she experienced when working with persons
affected by substance use disorders; and from Mary Beth Rasset, acupuncturist, on
alternative pain treatments.
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6. September 12, 2017: The prevention/harm reduction small group met first for two hours,
followed by the treatment/recovery and law enforcement small groups. During this
meeting, the small groups evaluated both MOC recommendations and brainstormed
additional ideas. Task force staff presented each small group with a list of carry over
bills. Before reporting back small group recommendations to the entire task force, the
members were directed to rank all of the potential recommendations discussed by the
small groups in order to see which ones had the most supp01t among the members.
7. September 27, 2017: The task force received the following presentations:
a. Kelley Bowden, Maine Medical Center, presented on the Snuggle ME program.
b. Jan Bindas~ Tenney and Bill Burns from Preble Street presented on the Homeless
Opioid Users Service Engagement (HOUSE) Pilot Project.
c. Nathan Cermelj from Liberty Bay Recovery Center presented about its residential
program.
d. Task force member Dr. Christopher Pezzullo, State Health Officer at DHHS,
presented on OHHs and other questions the task force submitted to the department.
The task force requested additional follow up information for the next meeting.

8. October 31, 2017: Dr. Pezzullo provided responses to the task force's follow up
questions. The small groups reported on their process and recommendations to the entire
task force. Before the next meeting, the members of the task force were directed to
identify their priorities among the recommendations supported by the small groups.
9. November 13, 2017: Task force staff compiled the priorities received from members and
presented it to the task force. The task force reviewed the aggregated priorities and
stmted developing recommendations. Before the next meeting, the members of the task
force were directed to draft narratives in support of any ideas that the task force had not
addressed in its discussions.
10. November 28, 2017: Task force staff drafted the task force's recommendations based on
the discussions from the last meeting. The task force reviewed the narratives presented
by members of the task force and further explored and refined those recommendations in
this final meeting.
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III.

RECOMMENDATIONS
Prevention and Harm Reduction

The task force considers prevention and hann reduction critical to addressing the opioid crisis. It
is more efficient to prevent problems before they begin. If a problem has developed, harm
reduction minimizes the negative impact. The task force focused on the following topics.
Parenting programs for families of drug-affected babies
Maine law requires a health care provider involved in the delivery or care of an infant born
affected, or suspected to be affected, by prenatal exposure to illegal or legal drugs and an infant
who has fetal alcohol spectrum disorder to notify DHHS (22 MRSA § 4011-B). In 2016, there
were 1,024 reports regarding infants exposed to substances, constituting 8.1 % of all live bit1hs in
8
Maine. This is a similar percentage to 2015, but is a 10% increase over 2013. If an infant is
identified as a drug-affected baby, additional medical care and programs to support a mother and
family, including parenting programs, should be provided.
A number of programs to support mothers, families and babies are available around the state.
The task force does not want to recommend one particular program but wants providers to be
aware of programs and how to access them. The Snuggle ME curriculum is considered to be a
pa1ticularly effective program and Kelley Bowden of the Maine Medical Center and Dr. Pezzullo
presented on the curriculum to the task force on September 27. The program screens pregnant
women for substance use disorders and provides treatment for women and infants. The program
was developed in partnership with DHHS. It was introduced in 2013 with copies of the
curriculum delivered to Maine hospitals with obstetric depaitments. The guidelines were also
posted to the futernet. The Maine Medical Center worked with Maine Quality Counts on a
webinar to encourage providers to use the program. The second edition of Snuggle 1vIE will be
released soon. In response to a question about barriers to the program's use, Ms. Bowden
mentioned that time was often a constraint for providers and that some providers already felt that
they knew what they were doing.
Other programs exist around the state to support mothers and drug-affected babies. The Children
and Recovering Mothers (CHARM) Collaborative is a group of providers in the Waldo County
area who meet monthly to coordinate care for these families. Providers include medical health
providers and behavioral health providers who provide both mental health and
medication-assisted treatment for substance use disorders. In the Bangor area, the Collaborative
Home Alternative Medication Program (CHAMP) Clinic is an outpatient weaning clinic for
babies born substance exposed or with Neonatal Abstinence Syndrome who need medical
treatment.
DHHS launched a pilot program in August 2016 called the Maine Enhanced Parent Project
(lvIEPP). The program pairs intensive outpatient treatment with the Positive Parenting Program
(Triple P). The Triple P is an evidence-based program of intensive parent education intervention
8

Substance Abuse Trends in Maine; State Epidemiological Profile 2017. Produced for the Maine Department
ofHealth and Human Services Statewide Epidemiology Outcomes Workgroup.
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for families experiencing moderate to severe behavioral or emotional difficulties. At the time of
launching the pilot, the department planned to serve 250 Maine parents annually at six sites
across the state (Scarborough, Kennebunk, Bangor, Ellsworth, Houlton and Machias). In March
2016, the Edmund N. Ervin Pediatric Center (EEPC) was awarded $15,000 by DHHS to support its
Triple P Pilot project. This public/private partnership included matching funds from MaineGeneral
and EEPC philanthropic activities (Cakes for a Cause) and was used to train providers in the
techniques of Triple P. Internal review board approval was sought and obtained and outcomes of the
project are being measured by Hornby-Zelleher on 25 families. The project will be completed by the
end of December 2017. In December 2016, the EEPC developed a proposal to join the MEPP and
was officially accepted into the program in the spring of 2017. Staff were hired in July 2017 and
contracts were developed with Crisis in Counseling and Community Health and Counseling Services
expanding the program to cover Oxford, Franklin, Androscoggin, Kennebec, Somerset, Waldo,
Knox, Lincoln and Sagadahoc counties. This program began seeing individual clients in October
2017 and sta1ted group sessions in November 2017. Twenty-two clients are in the program thus far.
Funding exists for another two years, until January 2020. 9 The task force would like the
department to consider expanding the program.

Recommendation: Request by letter that the Maine Department of Health and Human
Services report to the Joint Standing Committee on Health and Human Services by March
1, 2018 on the dissemination to providers of the updated Snuggle ME curriculum and other
evidence-based programs and recommend expansion of Positive Parenting Program to
parents and families who would benefit. (Appendix H.)
Long-acting reversible contraceptives
An overarching goal for the task force is to reduce the number of drug-affected babies by
preventing pregnancies for women at risk as well as helping pregnant women with substance use
disorders become and remain healthy during pregnancy. One family planning strategy for
women with substance disorders who wish to avoid an unplanned pregnancy is the use of a
long-acting reversible contraceptive (LARC). LARCs provide effective contraception for an
extended period with less vigilance by the individual. Examples include hormonal and
nonhormonal intrauterine devices and subdermal implants.
During the legislative interim, DHHS amended the MaineCare Benefits Manual, Chapter 45
(hospital services), to include reimbursement to providers for inserting a LARC during a
postpartum inpatient hospital stay, in addition to the existing payments to hospitals for
procedures relating to the birth (Diagnosis-Related Group payment). Women covered by
MaineCare who are in a hospital giving birth could be offered reproductive counseling while still
in the hospital and contraceptive options could include LARCs. The task force applauds this
change in MaineCare reimbursement and recommends that professional medical associations,
such as the Maine Medical Association, the Maine Osteopathic Association and Maine Nurse
Practitioners Association, conduct outreach to members to ensure awareness.

9

The current status of the MEPP and Triple P programs was provided by task force member Dr. Steven Diaz,
representing MaineGeneral Health.
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Recommendation: Request by letter that medical provider organizations communicate the
importance of counseling patients on the importance of and availability of long-acting
reversible contraception, including coverage under MaineCare. (Appendix I.)
Youth prevention programs
The task force believes that youth prevention is an imp01tant key to combatting the opioid
epidemic. In the past, prevention programs operated partly through Healthy Maine Partnerships.
Currently, the University of New England (UNE) is the substance use prevention services vendor
with a $2.3 million contract from the Maine Center for Disease Control within DHHS to provide
statewide substance use prevention services to Maine youth and young adults. The focus of
substance use prevention efforts is to reduce heroin use, alcohol use and binge drinking,
marijuana use and prescription drug misuse. UNE subcontracts with I 9 local community
agencies that work with the District Coordinating Councils for Public Health.
Different options for recommendations for prevention programs were considered. One option
was a pilot project in a specific area of the state that could generate findings to be applied to the
rest of the state. During the First Regular Session of the 128th Legislature, LD 144, An Act To
Create a Pilot Project To Reduce Substance Use Disorders among Youth in Piscataquis County
To Be Used as a Model for All Maine Communities, was sponsored by Representative Higgins
on behalf of the Maine Medical Association and was considered as a recommendation. The bill
was a concept draft aimed at developing a comprehensive prevention program in Piscataquis
County. The Joint Standing Committee of Health and Human Services had voted 11 "ought not
to pass" to 2 "ought to pass as amended." The minority report of the bill proposed to establish
the pilot project and this proposal was seriously considered as a possible recommendation of the
task force.
The task force determined that the prevention recommendations should focus on children. There
is evidence that youth prevention programs prior to high school are effective. Task force
members had differing perspectives about the optimal age for programs and program content. At
the November 28 meeting, members discussed the success of the Icelandic Model of Adolescent
Substance Use Prevention and task force member Malory Shaughnessy provided a peer reviewed
study. In the 1990s, Icelandic teenagers had high rates of substance use. The Icelandic model's
interventions, showed significant drops over a 20-year period between 1997 and 2007, in the
rates of adolescents reporting being drunk during the last 30 days, smoking one or more
cigarettes per day or having tried hashish once. In addition, the study reported substantial
increases in the proportion of adolescents spending time with their parents and their parents
knowing with whom their adolescents were spending time. 10 The model focuses on reducing
known risk factors for substance use while strengthening a broad range of parental, school and
community protective factors.
Task force members determined that the Maine Department of Education is in the best position
to identify the prevention programs that currently exist, programs that are most effective and
evidence-based and the best way to incorporate programs into the school curricula. The task
10

Inga Dora Sigfusd6ttir et al, "Substance use prevention for adolescents: the Icelandic Model." Health
Promotion International 24(1), 2008.
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force recommends that the Joint Standing Committee on Education and Cultural Affairs consider
the proposed legislation relating to this recommendation. The task force also believed it would
be useful for the Depaitment of Education to examine other programs, including the Icelandic
Model, to see if there might be lessons that could be applied in Maine schools.
Recommendation: The Joint Standing Committee on Education and Cultural Affairs
consider introducing legislation directing the Department of Education to establish a work
group to evaluate existing drug prevention programs targeting school-age children and
how to incorporate those programs into educational curriculum. The work group should
include the Maine Education Association, Maine School Management Association, Maine
Principals Association, Maine Interscholastic Athletic Administrators Association and
representatives of law enforcement and organizations that promote and facilitate programs
relating to public health, drug prevention and the welfare of children. (Appendix J.)

Stigma-reducing language
Terminology, such as "substance abuse," "addict," and "drug addicted baby," used in the
discussions of substance use disorders can suggest moral failing, that substance use disorder is a
choice, or that a person lacks willpower or character. The task force discussed the importance of
placing the person first rather than the disorder first and using language that does not include
judgment. It is more accurate and less stigmatizing to use terminology such as "substance use
disorder," "person with a substance use disorder," "person in recovery," "drug-affected baby,"
and so on. Medical organizations such as the American Medical Association, American Society
of Addiction Medicine and others have recommended the use of clinical, non-stigmatizing
language for substance use issues. 11 The task force is aware that care must be taken to ensure the
continuation or compliance with federal programs that may use outdated language.
Person-first language is also increasingly being adopted for other medical conditions or
disabilities. In 2012, the Maine Legislature enacted Public Law 2011, chapter 542, An Act To
Implement the Recommendations of the Depa1tment of Health and Human Services and the
Maine Disabilities Council Regarding Respectful Language, which stressed the importance of
treating individuals with intellectual disabilities with respect and dignity and replaced the
language of "mental retardation" and "the mentally retarded" with "intellectual disability" and
"persons with intellectual disabilities." Task force members agreed that a similar legislative
change regarding substance use disorders would be beneficial.
Recommendation: The Joint Standing Committee on Health and Human Services consider
introducing legislation directing the Office of the Revisor of Statutes to update the statutes
to reflect current terminology relating to substance use disorders. {Appendix K.)

JJ See Memorandum to Heads of Executive Departments and Agencies, January 9, 2017, from Director Michael
P. Botticelli, Executive Office of the President, Office of National Dmg Control Policy on "Changing Federal
Terminology Regarding Substance Use and Substance Use Disorders" at:
https://www .whitehouse.gov/sites/whitehouse .gov/files/images/Memo%20%20Changin g%20F ederal%20Term inology%20Regradin g%20Su bstance%20Use%20and%20Substance%20U se%2
0Disorders.pdf.
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Preventing diversion of prescription drugs
The prevention/harm reduction small group considered the suggestion of the MOC to increase
safe storage and disposal of prescription drugs and public education and believed that it is critical
to being able to prevent prescription medications from being used by someone who has not been
prescribed the medication. Increasing safe storage and disposal has consistently been suggested
as a strategy for reducing the supply of prescription opioids available for diversion.
Currently, the Maine Drug Enforcement Agency (MDEA) holds prescription drug take-back
days twice a year. The MDEA bears all of the costs of publicizing collection events with posters
and press releases, providing collection boxes and bags and transporting the medications to an
incinerator located in Massachusetts. MDEA coordinates the event with all of the sheriffs
offices and police departments across Maine. Sheriff's offices and police departments provide
collection points, which are monitored by an off-duty officer. The sheriff's offices and police
departments then transport collection boxes to a regional collection point where the MDEA has
large trucks waiting to transport them to the incinerator. The only cost incurred by the sheriffs
offices or police departments is the cost of paying the off-duty officer to staff the collection
point. Many sheriffs offices and police departments maintain drug collection boxes in their
stations throughout the year so that the public does not have to keep unneeded prescription drugs
in their homes and medicine cabinets while waiting for a spring or fall collection event. The
sheriff's offices and police departments store those dmgs in their evidence lockers and turn them
in on the federal collection dates in the spring and fall. The collection boxes cost approximately
$1,000 each to buy. Collecting and storing the drugs are done by existing sworn staff, at no
12
additional cost. Drug take-back programs are an example of a strategy that straddles the silos
of prevention, harm reduction and law enforcement.
Drug take-back programs in pharmacies are an example of a product stewardship program and
are another option to have the public return unneeded prescription drugs. Under this model,
phaimacies would maintain secure collection receptacles, provide mailer envelopes, or hold
collection events where customers could return prescription drugs. More infmmation is needed
about how to craft a system like this in Maine and how it would be financed.
The Attorney General infonned the task force about Deterra, which is a product that deactivates
certain pharmaceuticals by using a chemical process. This might be a method to explore more
for use in disposing of prescription drugs with area agencies on aging, law enforcement
collection sites and pharmacy collection sites.
The task force agrees that prescription drug take-back programs that do not create any
consumer-borne costs for those programs should be promoted.

Recommendation: Promote programs that take back prescription drugs but do not create a
consumer-borne cost for that program. Request by letter that Maine Drug Enforcement
Administration report to the Joint Standing Committee on Criminal Justice and Public
12

Most of the text of the section on the DEA program was provided by task force member Sheriff Jeffrey
Trafton, on behalf of the Maine Sheriffs Association.
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Safety by March 1, 2018 about the successes of the drug take-back programs; publicity of
the collection days; the use of alternative drug disposal options, such as Deterra; and
expanded placement of take-back units in appropriate law enforcement or other secure
facilities. (Appendix L.) Request by letter to the Maine Board of Pharmacy that it require
pharmacies to place a notice in an obvious place informing patients about disposing of
excess medication. (Appendix M.)
Syringe exchange programs
The task force considered syringe or hypodermic apparatus exchange programs as a harm
reduction strategy; although, the task force did not make a recommendation about these
programs.
Maine has five syringe exchange programs in Bangor, Ellsworth, Machias, Portland, and
Augusta, which currently serve about 2,700 people per year. Syringe exchange programs allow
clients to bring their used needles and obtain sterile supplies in exchange. Maine's syringe
exchange programs have consistently collected more syringes than they have dispensed. Staff at
those programs develop relationships with clients over time and connect them with resources
when they are ready for help with their substance use. In addition to making treatment referrals
for persons with substance use disorders, syringe exchange programs help prevent the spread of
hepatitis C and HIV infections by providing clients sterile syringes.
The most common way hepatitis C is transmitted is through intravenous drug use. The U.S.
Centers for Disease Control has reported that one-third of injection drug users are infected with
hepatitis C. A single treatment for hepatitis C can cost up to $90,000 and Maine has spent
between $18 million and $24 million per year on treatment since 2015. 13 HIV is also transmitted
through intravenous drug use and for every $1 invested in a syringe program, $7 is saved in HIV
treatment.
The Maine Legislature recently considered two bills relating to syringe exchange programs. Pait
of LD 1326 (128th Legis. 2017), An Act to Reduce Morbidity and Mortality Related to Opioid
Misuse, included an appropriation of $75,000 to DHHS for syringe exchange programs for each
year of the biennium. The committee amendment to the bill removed the funding for the syringe
exchange program. LD 1552 (127th Legis. 2015), An Act to Reduce Morbidity and Mortality
Related to Injected Drugs, proposed to appropriate $75,000 for existing and new syringe
exchange programs as part of a bill related to change the methodology for distributing funds for
syringe exchange programs and directing DHHS to amend the rules regarding distributing funds,
certification renewal and complaint investigations. A Senate Amendment removed the
appropriations section. Public Law 2015, chapter 507 was enacted without funding for syringe
exchange programs.

13
Some of the info1mation about syringe exchange programs and the statistics about Hepatitis Care from the
series on hepatitis C by MainePublic, available at http ://mainepublic .org(tenn/hepatitis-c#stream/O .
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Treatment and Recovery
The task force spent a considerable amount of time considering treatment options. Because more
than one person a day dies from an opioid overdose, providing treatment is critical to addressing
the immediate needs of the crisis.
Hub and spoke and opioid health home treatment models
During the First Regular Session of the 128th Legislature, Representative Vachon sponsored
LD 1430, An Act To Develop a Statewide Resource and Referral Center and Develop
Hub-and-spoke Models To Improve Access, Treatment and Recovery for Those with Substance
Use Disorder. The bill was carried over into the Second Regular Session. The bill was based on
the Vermont hub and spoke model for substance use disorders treatment. Hub and spoke has
also been more generally applied in healthcare, not just to substance use disorders treatment. In
general, the model means having multiple practicing sites with the hub as the anchor site for the
specialty and the spokes connecting secondary sites serving the specialty.
In Vermont, the hub and spoke model consists of two access points for medication-assisted
treatment. The hubs are regional specialty substance use disorders treatment centers that provide
intensive treatments to patients. Spokes are more general medical settings, including primary
care practices that provide enhanced staffing to treat substance use disorders and receive
consultation support from the hubs. In Vermont, the hubs initiate treatment, provide care
through the period of initial stabilization, coordinate referrals to ongoing care and provide
consultation and suppo1t to ongoing care. Medication-assisted treatment is provided in hubs.
Spokes are the ongoing care system, including health and addiction professionals who monitor
adherence to treatment, coordinate access to recovery supports and community services and
provide counseling, care coordination and case management. The state funds some additional
staffing for the spokes. 14 The task force received a peer reviewed article and presentation that
indicated that the hub and spoke model has been associated with substantial increases in
Vermont's substance use disorders treatment capacity, with Ve1mont now having the highest
capacity for treatment of substance use disorders in the U.S., including a 64% increase in
physicians waivered to prescribe buprenorphine and a 50% increase in patients served per
waivered physician. 15
The Maine model is based on similar principles as the Vermont model but is adjusted for the
Maine healthcare environment. Individuals with the greatest acute need receive services in the
hubs, including inpatient care and intensive outpatient services, until they are stabilized and can
be transferred to spokes, usually primary care practices for MAT, behavioral health supports and
other medical services. Included in the model is support from the hubs to the spokes, including
training. It is the combination of medical and behavioral treatments that constitutes the
14

"Vermont. Case Study: Medication Assisted Treatment Program for Opioid Addiction." Accessed:
http://www.astho.org/Health-Systems-Transformation/Medicaid-and-Public-Health-Partnerships/CaseStudiesN ermont-MA T-Program-for-Opioid-Addiction/.
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John R. Brooklyn and Stacey C. Sigmon. 2017. "Vennont Hub-and-Spoke Model of Care for Opioid Use
Disorder: Development, Implementation, and Impact," Journal ofAddiction Medicine 11(4) 286-292.
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evidence-based treatment of IMAT. The task force differentiated the long-term needs of
establishing the hub and spoke model and the short-term need to increase immediate access to
treatment. LD 605, An Act To Support Evidence-based Treatment for Opioid Use Disorder, was
carried over to any special or regular session of the 128th Legislature. LD 605 is a possible
vehicle to provide increased funding for the uninsured to receive IMAT services.
The task force had considerable discussion about the intersection between the hub and spoke
model and the department's OHHs initiative. In the spring of 2017, the Legislature authorized
funding in a supplemental budget for the creation of OHHs to provide services to MaineCare
members and the uninsured. The department applied for and received a waiver from the Centers
for Medicare and Medicaid Services. OHHs are based on an integrated care delivery model,
including substance use disorders counseling, care coordination, MAT, peer support and
recovery coaching and medical consultation. OHHs are based on the behavioral health home
model, which also integrated physical and behavioral health services. Both BHHs and OHHs are
reimbursed with a bundled rate rather than fee-for-service. The department asserted in a
follow-up written statement that the OHR program serves the same purpose as the hub and spoke
model and changing the model would be unnecessary and lead to duplication. Some task force
members raised issues of access to uninsured slots and Dr. Pezzullo commented that members
should let the department know if individuals needing treatment services are unable to gain
access. Additionally, some task force members identified the following concerns about OHHs:
the staffing required in OHHs; the bundled payments do not support treatment of patients in
more acute phases of need; potential future effectiveness of OHHs across the continuum of need;
and lack of current evidence that this program will meet the state's needs.
The task force determined that the department should be involved in considering how the hub
and spoke model, such as the one operated by MaineHealth (outlined in Appendix N.), could be
extended in LD 1430, especially given the waiver already received by the depaitment for OHHs.
The department has focused on providing services in the OHHs for the uninsured through grant
funds. The task force identified a significant need for IMAT services for individuals involved in
the criminal justice system. DHHS will be asked to consider providing treatment to the
uninsured in pre-diversion programs, minimum security offenders in jails and prisons, jail
inmates on community and work release programs and state inmates in supervised community
confinement or community transition programs (work release).
Recommendation: Request by letter to the Department of Health and Human Services to
examine how the opioid health home model under the current Centers for Medicare and
MaineCare Services waiver could integrate evidence-based treatments, such as the hub and
spoke model in LD 1430, an Act To Develop a Statewide Resource and Referral Center and
Develop Hub-and-spoke Models To Improve Access, Treatment and Recovery for Those
with Substance Use Disorder, which was carried over to any Special or Regular Session of
the 128th Legislature. Fund a continuum of evidence-based services of differing intensities
that meet the treatment needs of individuals depending upon stage of recovery, including
integrated medication-assisted treatment across the state and integrated community-based
relationships. (Appendix 0.)
Recommendation: The Joint Standing Committee on Health and Human Services consider
introducing legislation, such as LD 605, An Act To Support Evidence-based Treatment for
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Opioid Use Disorder, that immediately increases access to treatment across the state for
patients, including those who lack insurance or the means to pay, by increasing grant funds
available to evidence-based programs that provide treatment to patients at varying levels of
acuity. Request by letter that the Department of Health and Human Services, within
existing financial resources, immediately increase access to treatment across the state for
patients, including those who lack insurance or the means to pay, by increasing grant funds
available to evidence-based programs that provide treatment to patients at varying levels of
acuity. Request that the Department of Health and Human Services consider allowing
minimum security offenders in custody or people in community release programs to access
treatment slots for the uninsured. (Appendix P.)
Access to treatment
Increasing access to treatment for substance use disorders includes both increasing the available
slots for the uninsured as well as increasing access to health insurance coverage. Under both
Maine law and the federal Affordable Health Care Act (ACA), insurers are required to have
parity of coverage for both physical and mental health issues. Providers of treatment services on
the task force express concern for treatment access for those without insurance rather than
concerns about individuals with insurance being denied coverage for substance use disorders
treatment. Employment and returning to employment is an important pait of long-term recovery.
However, because of the complexity and lack of awareness about this pa1ticular provision of the
ACA, people in recovery who have been able to enter or reenter the workforce are missing out
on accessing health care. Moreover, this provision allows persons who do not have employerbased coverage access health insurance through the exchange. The task force supported the
introduction of LR 2755, An Act Regarding Health Care Ombudsman Services, sponsored by
task force member Representative Karen Vachon. LR 2755 would create an ombudsman to help
individuals complete an application with healthcare.gov in order to qualify for premium tax
credits and special enrollment and to obtain private health insurance outside of the regular
enrollment period. The appeal to the Legislative Council for LR 2755 was successful and the
bill was approved for introduction on November 30, 2017.

Recommendation: Increase access to treatment across the state by increasing access to
health insurance coverage. Write a letter to the Legislative Council to support the
introduction of LR 2755, An Act Regarding Health Care Ombudsman Services, in the
Second Regular Session. LR 2755 would assist people with accessing health insurance.
(Appendix Q. The appeal to the Legislative Council was successful and the bill was
approved for introduction.)

Confidentiality provisions under 42 U.S.C. § 290dd-2 and 42 C.F.R. Part 2
Federal law sets forth confidentiality requirements for records of patients with substance use
disorders, including requirements for patient consent at 42 U.S.C. § 290dd-2. The
Confidentiality of Substance Use Disorder Patient Records Rule, 42 C.F .R. Part 2, adopted
pursuant to 42 U.S.C. § 290dd-2, imposes restrictions upon the disclosure and use ofrecords of
patients with substance use disorders maintained by individuals, entities, medical facilities and
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medical personnel that provide substance use disorders diagnosis, treatment, or referral for
treatment (42 C.F.R. §§ 2.11 & 2.12(b)). Maine law on the confidentiality of health care records
incorporates the federal law statute and regulations. 22 M.R.S. § 1711-C(l l). The
confidentiality requirements on programs that provide substance use disorders treatment are
more restrictive than the Health Insurance Portability and Accountability Act (HIP
in three
1
important ways, which creates significant challenges for addressing the opioid crisis.

AA)

First, the definition of patient under the federal regulations is expanded to include any individual
who has applied for or has been given a diagnosis or treatment of a substance use disorder (42
C.F.R. § 2.11). Organizations that receive federal alcohol and drug treatment funds are restricted
from even acknowledging that a person might have requested (not even received) services from
the program, unless a specific release is obtained from the client.
Second, these programs are required to obtain written patient authorization in advance of each
and every disclosure to other healthcare professionals, including information about treatment,
payment, or operations (42 C.F.R. § 2.31). The confidentiality requirements limit the
coordination of care between organizations treating the patient and results in a fragmented
system along the continuum of care. Primary care providers who are responsible for the "whole
person" do not have ready access to important inf01mation about some patients' health care
conditions and needs, adding to the stigma of substance use disorders by treating substance use
disorders differently from every other medical condition (even though stigma was the purpose of
the rule in the first place). The confidentiality requirement also means that substance use
information must be protected and shared differently and requires cumbersome and expensive
workarounds in electronic health records systems that are neither patient nor provider friendly.
This contributes to higher healthcare costs for patients with behavioral health needs.
Finally, these programs are required to maintain a list of all disclosures made ( 42 C.F.R.
§ 2.13(d)), requiring programs to establish a tracking and reporting system and further adding to
the cost of the programs.
In support of providing comprehensive treatment to a person receiving treatment for substance
use disorders along the entire continuum of care, the task force recommends the federal
government amend the confidentiality statute and regulations.

Recommendation: Request by letter to the congressional delegation, U.S. DHHS, SAMHSA
and CMS that the federal government amend 42 CFR Part 2 and the related federal statute
to allow for greater information sharing between providers regarding medication-assisted
treatment and treatment of substance use disorders. (Appendix R.)
Housing and recovery residences
Lack of safe housing is a barrier to a person's treatment and recovery from substance use
disorders. When a person lacks safe housing, he or she is more likely not to engage in treatment
or to relapse. A "recovery residence" is a type of safe housing in which people in treatment live
together to support each other's recovery, but it is not a treatment center or facility. "Recovery
16
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residence" is the less-stigmatizing term than "sober housing," because it is focused on a person's
recovery generally rather than identifying recovery only by an abstinence-based model.
Currently, there is no state certification process for recovery housing, resulting in an
inconsistency in quality among residences. The Maine Association of Recovery Residences has
developed voluntary criteria for identifying recovery housing that would allow residents to
engage in medication-assisted treatment. The task force supports increasing access to housing
and recovery residences. This is consistent with recommendations from the President's
Commission on Combating Drng Addiction and the Opioid Crisis. 17
Discussions around housing occurred at numerous meetings of the task force. In planning for
treating an individual with substance use disorders comprehensively such as in the hub and spoke
model, housing is a critical "spoke" that supports a person with other facets of life, including
maintaining employment. At the July 12 meeting, each member of the task force identified three
barriers to implementing strategies to address the opioid crisis and lack of safe housing was a
recurring theme. During the task force's small group meetings, both the prevention/harm
reduction and treatment/recovery groups identified safe housing as a key component to recovery.
There are different approaches to housing models. For example, the Housing First model is an
approach that seeks to quickly find homes for persons experiencing homelessness and then
connect them with case management and other suppo1t services to address substance use, mental
health, or other conditions. It recognizes that homelessness and substance use disorders are often
correlated. Another approach was presented by Preble Street at the September 27 meeting. This
pilot project, the Homeless Opioid Users Service Engagement (HOUSE), is the subject of LR
2744, An Act to Save Lives and Create the Homeless Opioid User Service Engagement Pilot
Project (sponsored by Representative Gattine). If enacted and funded, the project would target
50 people from community hospitals, the criminal justice system and the streets and connect
them with low-barrier medication-assisted treatment, a variety of stable housing options to suit
the person's needs and wrap-around services, including case management and peer recovery
supports. LR 2744 did not receive initial approval by the Legislative Council for introduction to
the Second Regular Session of the 128th Legislature but the task force supported the sponsor's
appeal. The appeal to the Legislative Council for LR 2744 was successful and the bill was
approved for introduction on November 30, 2017. Similarly, the task force supported the
introduction of LR 2521, An Act to Ensure Quality of and Increase Access to Recovery
Residences (sponsored by Senator Bellows). The appeal to the Legislative Council for LR 2521
was successful and the bill was approved for introduction on December 14, 2017.
Recommendation: Support the development of recovery housing that meets the standards
of the Maine Association of Recovery Residences to serve people in recovery, including
those who are engaged in integrated medication-assisted treatment. Request by letter that
Maine State Housing Authority convene a work group to develop a certification process for
recovery housing and investigate available funding resources and development
opportunities and to report quarterly to the Joint Standing Committees on Labor,
Commerce, Research and Economic Development and Health and Human Services for one
17
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year, beginning March 1, 2018. The work group should include Maine's Department of
Health and Human Services, Finance Authority of Maine, Maine Real Estate and
Development Association, the Maine Association of Recovery Residences and
representatives of treatment providers, housing services, affordable housing developers, the
recovery community and persons experiencing homelessness. (Appendix S.)
Recommendation: Write a letter to the Legislative Council to support the introduction of
two bill requests in the Second Regular Session dealing with recovery housing that are on
appeal: LR 2744, An Act to Save Lives and Create the Homeless Opioid User Service
Engagement Pilot Project and LR 2521, An Act to Ensure Quality of and Increase Access
to Recovery Residences. (Appendix Q. The appeals to the Legislative Council for LR 2744
and LR 2521 were successful and the bills were approved for introduction.)
Access to infonnation regarding treatment services
The task force frequently discussed the lack of accessibility or availability of information about
treatment services. The task force identified that people do not know where to go to receive
information on services and that information on services available is often inaccurate. Members
of the law enforcement small group commented that law enforcement, District Attorneys and
judges often do not know who to call to refer people to treatment services. In the
prevention/harm red1,.1ction small group, the members discussed the value of having greater
access to real-time information about available resources, including a treatment locator map by
county, the availability ofIMAT services (included primary care providers who prescribe
suboxone), wait list information and provider capacity data. Task force discussions centered
around developing a central database with this information and associated challenges.
The task force also heard that 2-1-1, a DHHS program that is operated through a contract with
United Way and Opportunity Alliance, also has incomplete inf01mation and would benefit from
access to the central database suggested above. 2-1-1 is a free, confidential resource to connect
people to information to resources around the state, including health and human services, energy
assistance, disaster information and volunteer opportunities. 2-1-1 launched a separate Opiate
Helpline in April 2016 which received 541 calls between April 1, 2016 and November 1, 2017.
The Opiate Helpline provides immediate warm referrals to services for women who are pregnant.
The task force heard from members that the database used by 2-1-1 has incomplete information
about providers and lacks information about treatment services in some areas of the state. In
addition, many people in Maine do not know about the services offered by 2-1-1.

Recommendation: Request by letter to Maine Department of Health and Human Services
that the department evaluate the options for developing a database of available treatment
services, including what information the database would contain; whether it could include
real-time data and the usefulness of that data; how to accurately identify provider capacity
and waitlists; how much it could cost; and how it could be implemented and funded. The
department shall report back to the Joint Standing Committee on Health and Human
Services by March 1, 2018. (Appendix T.)
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Recommendation: Request by letter to the 2-1-1 program of United Way of Mid-Maine
that it report by March 1, 2018 to the Joint Standing Committee on Health and Human
Services regarding ongoing improvements to the 2-1-1 service in relation to substance use
disorders, including the accuracy and ease of accessibility of the website and database; staff
training; outreach to providers who are not licensed by the State; and plans for increasing
public awareness of 2-1-1 services, including alternative platforms to access information.
(Appendix U.)
Peer recovery centers and recovery coaching
Outside of the medical model of recovery, peer recovery centers and recovery coaching are an
important part of the social support services that assist individuals in recovery. Recovery
coaches are another resource for people in recovery. Recovery coaches offer support and help
obtain community-based services. Recovery coaches provide hope and can be a positive role
model. They work with individuals in recovery to develop individual recovery plans and with
friends or family members who have been affected by another person's substance use disorder.
They are not therapists, counselors, clinicians, clergy, or 12-step sponsors, although training in
recovery coaching is required.
Peer support programs are based on persons in recovery using their experiences to assist others
in their recovery journeys. Peer centers operate in the mental health arena in addition to the
substance use disorders setting. In Maine, the Portland Recovery Community Center and the
Bangor Area Recovery Network offer services to people in recovery from substance use
disorders, connect them with a wider community of people living in recovery, promote social
activities and connect them with multiple services in the community.
In the Second Regular Session of the 127th Legislature, two bills were enacted that included the
development of new peer support recovery centers recognizing the importance and value of these
centers. The two laws resulted in two request for proposal (RFP) processes (both RFPs are
currently in process and are not yet completed). The two peer support recovery centers
authorized in Public Law 2015, chapter 378, Part D were specified in the law to be in
"underserved areas of the state." The peer suppo1t recovery centers in Public Law 2015, chapter
481, Patt F, specified that two of the three centers authorized in the law must be in "currently
underserved areas that are outside of Maine' s largest cities." However, the definition applied in
both RFPs defined "underserved" as at least 30 miles from Augusta, Bangor, Lewiston, Portland
and Waterville. Underserved is equated with rural even though the law only specified that two
centers must be outside of Maine' s largest cities. The statute, in contrast, defined "underserved"
as any area with a documented need for recovery services that did not have those resources.
Members of the task force expressed concern over the underserved definition in the RFPs
because organizations in urban areas were unable to apply for either RFP even though there is a
significant need for peer recovery services in both urban and rural areas. The concern over the
requirements for individuals providing peer support services in the centers to be Certified
Intentional Peer Support Specialists - a model developed for mental health peer services rather
than substance use disorders peer services. During task force meetings, Dr. Pezzullo recognized
the issues presented, but was unable to talk specifically about RFPs that are cu1Tently active and
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in process. He assured the task force that the department clearly heard the concerns from the
task force.
Law Enforcement

The intersection between the criminal justice system and mental illness, substance use disorders
or co-occurring disorders is well known. SAMSHA estimates that 53% of people in state prisons
and 68% in jails have substance use disorders compared to approximately 8.5% of the general
public aged 18 or older. 18 In 2016, new male admissions into the Maine prison system for
sentences for drug crimes accounted for 31 % of the year's total admissions (a 37% increase over
the year before). For female admissions, sentences for drug crimes accounted for 41 % of the
2016 admissions, an 18% increase over the year before. In addition, 67% of the male prisoners
and 89% of female prisoners admitted into Maine Department of Corrections facilities were
assessed as needing outpatient or residential substance use disorders treatment. (See Appendix
V.)
Pre-diversion programs
The task force discussed the lack of services to divert individuals before being charged with a
crime. However, task force member Sheriff Jeffrey Trafton reminded the task force that law
enforcement officers' interactions with individuals with substance use disorders are frequently
community activities unrelated to criminal activity. Maine lacks pre-trial diversion programs
available to municipal police depaitments, county sheriff offices and the state police.
In early 2017, a pre-diversion pilot program was launched in Bangor funded by a planning grant
from the Open Society Foundation received by the Health Equity Alliance. The Law
Enforcement Assisted Diversion (LEAD) program is pre-charge diversion program that connects
people with treatment and recovery services. It was originally launched in Seattle in October
2011. The Bangor program is based on the LEAD program. LEAD is a coalition of law
enforcement agencies, public officials and community groups. The program diverts low level
drug and prostitution offenders into treatment and support services, including immediate referral
to a case manager, rather than processing those individuals through the criminal justice system.
An evaluation of the program, conducted by University of Washington researchers, concluded
that there were positive effects on criminal recidivism over six-month and longer time frames as
well as improved housing outcomes. 19
A different type of program operated by the Scarborough Police Depaitment, modeled on the
Gloucester, Massachusetts program and replicated by some other Maine police departments, is
Operation HOPE. Operation Hope is a program that connects persons with substance use
is "Guidelines for Successful Transition of People with Mental or Substance Use Disorders from Jail and Prison:
Implementation Guide" (2017), Substance Abuse and Mental Health Services Administration. Available at:
https://store.samhsa.gov/shin/content//SMA 16-4 998/SMA 16-4998 .pdf.
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disorders who have detoxed with an inpatient treatment facility. Task force members are
concerned about the level of need considerably outstripping resources for these programs, as well
as the lack of in-state programs, resulting in some individuals going out of state to inpatient
treatment programs.
Recommendation: Develop and fund pre-charge diversion programs at the municipal,
county and state levels. The programs should be developed in consultation with
prosecutors, law enforcement and other stakeholders. The programs should minimize a
person's contact with the criminal justice system by connecting them with treatment and
recovery services, including case management, at the appropriate level based on an
assessment process. Because implementing this recommendation requires the cooperation
of the criminal justice and treatment communities, the Joint Standing Committees on
Health and Human Services, Criminal Justice and Public Safety and Judiciary should
collaborate to develop the program.
Specialty courts
The task force received a presentation in April on Drug Courts from Anne Jordan, Esq., Manager
of Criminal Process and Specialty Dockets, State of Maine Judicial Branch. 2 Following an
initial pilot project in Cumberland County, known as Project Exodus, Drug Courts were first
recognized in legislation in Maine in 2000. The Maine Judicial Branch currently operates six
adult drug treatment courts in Alfred, Pmiland, Auburn, Bangor, Ellsworth and Machias/Calais;
a co-occurring disorders and veterans comi in Augusta; and three family recovery comis in
Bangor, Auburn and Augusta. In 2016, six adult drug treatment courts served 204 individuals,
the co-occurring disorders and veterans court had 43 participants and the family recovery courts
served 73 parents. Fifty-two individuals successfully graduated from the adult drng treatment
court/ co-occun-ing disorders and veterans court in 2016 while 62 were terminated for noncompliance.

°

Court personnel costs for all comis are covered by the State General Fund while funding for
counseling, treatment and case management services are primarily from DHHS through federal
SAMHSA grants. Additional funding for treatment of veterans is provided by the U.S. Veterans
Administration. The General Fund is used to provide additional resources for participants in the
family recovery courts. In 2017, the Coordinator of the Specialty Dockets was able to secure
outside funding to provide intensive training for the adult drug treatment court teams in March
and October, 2017 and specialized training for the co-occurring disorders and veterans comi
team scheduled for August 2018. The Maine Bureau of Highway Safety has provided federal
highway safety grant funds to send the adult drug treatment court judges to specialized training
for judges regarding individuals driving under the influence of drugs in November 2017.
Each participant is screened before admission and is required to adhere to a rigorous program of
substance use disorders counseling, mental health and trauma treatment, random drug screening,
work or educational requirements and to pay all fines, restitution, child support and taxes. Each
participant is required to maintain sobriety and abide by all court-ordered conditions of
20
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participation. Failure to meet any of these requirements can result in termination from the
program and/or the imposition of new comt sanctions.
The most recent evaluation of the adult drug treatment comts and the co-occurring disorders and
veterans court concluded that the recidivism rate (defined as a criminal conviction within 18
months post-admission) for graduates was 16% compared to 49% for those who were admitted
but later expelled. Individuals with similar criminal histories but on probation had recidivism
rates between 39.6% and 47.1%.
During the presentation, Anne Jordan stated that the adult drug treatment court process
represents a significant savings to the state's criminal justice system. For every $1 spent of adult
drug treatment court treatment, $1.87 in savings is realized. The average savings per participant
in adult drug treatment comt is estimated to be $12,218. In addition, the family recovery courts
can point to 66 drug-free babies born to participants. Estimated average costs for drug-affected
babies in Maine is $32,016 per newborn compared to a national average of $4,000 per child for
drug-free newborns, meaning that the deliveries of these 66 babies saved more than $1.8 million
in medical costs.
The task force supports the use of drug courts and other specialty courts and co-occurring comts
such as Veterans' Comt. LD 111, An Act To Establish an Additional Veterans Treatment Comt,
was carried over by the Appropriations and Financial Affairs Committee, on the Appropriations
Table.
Recommendation: The Joint Standing Committee on Judiciary consider introducing
legislation that develops additional drug courts or increases access to existing drug courts
across the state and provides the necessary funding.
Treatment programs in jails and prisons
Task force members identified a lack of treatment for mental health issues and substance use
disorders in the state's county jails and prison facilities. There is a need for assessments and
services for those in jails awaiting trial as well as those who have been sentenced up to one year.
Services for inmates and their families upon release into the community are insufficient.
Individuals released into the community with untreated substance use disorders are at particular
21
risk of unintentional overdose in the days and weeks after release.
There are no IMAT services in the jail system except for a Vivitrol trial pilot recently launched
in the Penobscot County Jail. There are therapeutic community programs such as peer-based
recovery suppo1ts. Kennebec County also has a program with a case manager (sheriff deputy)
component that follows individuals after release. Concerns about diversion of suboxone is a
significant issue in the jails at the same time as a significant proportion of the population have
mental health and substance use disorders needs that go unaddressed.
Residential and outpatient treatment programs for substance use disorders are available in the
Department of Corrections (DOC) facilities. As of July 2012, DOC contracted with Correct Care
21
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Solutions to provide medical and behavioral health services to adult and juvenile populations. In
July 2015, CCS began providing substance use disorders treatments in adult facilities paid for by
both DOC and DHHS funding. Day One provides substance use disorders treatment at Mountain
View Correctional Facility paid for by DHHS funding. The residential treatment program
graduated 54 prisoners but the need is great and at the end of 2016, 150 male prisoners were on
the DOC waitlist for residential substance use disorders treatment. In 2016, 518 male prisoners
and 181 prisoners completed outpatient substance use disorders treatment while incarcerated. At
the end of 2016, 540 male prisoners and 55 female prisoners remained on the waitlist for
outpatient treatment. (See Appendix X.)
Criminal justice institutions around the country are beginning to develop treatment programs for
substance use disorders. For example, the Barnstable County Sheriff's Office launched a
Vivitrol program in April 2012 to sentenced inmates as part of a comprehensive pre-release
program. The program includes both the monthly Vivitrol medication and behavioral health
services. Two hundred and one inmates were served in Barnstable County in the first three years
of the program. Approximately 40-45% of these inmates remained in treatment or completed
treatment and remained sober (higher than success rates without treatment) and 82% of those in
the program have not been incarcerated. Since April 2012, the program was extended to selected
pre-trial inmates through the Barnstable County Drng Comt and the Barnstable County Sheriffs
Office has assisted other counties in Massachusetts with offering Vivitrol programs. 22
Task force members support IMAT programs being offered in conectional institutions as well as
connecting minimum security inmates in jails and prisons to hub and spoke treatment programs
outside of the institutions. Minimum security jail inmates on work release programs, prison
inmates in supervised community confinement and community transition programs could be
connected to treatment programs.
Task force members commented that, over time, knowledge and philosophies around appropriate
treatment and programming for inmates change. A permanent advisory commission to
conectional facility administrators would allow institutions to keep up with the evolution of
knowledge and needs.

Recommendation: The Joint Standing Committee on Criminal Justice and Public Safety
consider introducing legislation that develops and funds assessments and services in jails
upon intake for mental health and substance use disorders, including integrated
medication-assisted treatment.
Recommendation: The Joint Standing Committee on Criminal Justice and Public Safety
consider introducing legislation that develops and funds assessment and services for people
in jails and prisons for mental health and substance use disorders, including integrated
medication-assisted treatment and access to hub and spoke services in the community, for
people serving their sentences.
Recommendation: The Joint Standing Committee on Criminal Justice and Public Safety
consider introducing legislation that develops and funds programs that prepare inmates for
22
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their release into the community, including connections with integrated medication-assisted
treatment and access to hub and spoke services in the community. These programs should
include family members or other supportive people in the inmate's life so they can be
natural supports during reintegration.
Recommendation: The Joint Standing Committee on Criminal Justice and Public Safety
consider introducing legislation that enacts an advisory board to advise the Department of
Corrections and county or regional jails on the treatment programs and rehabilitation
needs of the facility populations. The advisory board will evaluate on an ongoing basis
existing services and evidence-based practices for managing the needs of offenders and
pretrial defendants and recommend the implementation of appropriate programs.
(Appendix W.)
Forfeiture funds and availability of data
Task force members recognize the serious need to fund programs for individuals involved in the
criminal justice system because of their substance use disorders, including pre-diversion
programs, Drug Courts, treatment programs, and post-release into the community. The task
force supports sections 1 and 4 of LD 1429, An Act Regarding the Epidemic of Opiate Abuse, a
bill submitted by the Attorney General, which has been carried over to any Special or Regular
Session of the 128th Legislature. The bill includes a section that would allow flexibility in
distributing funds received from civil forfeitures. The agency that made a substantial
contribution to the investigation or prosecution of a criminal case could request that the funds be
redirected to a law enforcement agency that provides case management and other social services
to persons with substance use disorders.
Separately, section 4 of the bill would allow certain aggregate data to be reported from the
prescription monitoring program that would allow policy makers to see trends in prescribing
rates and compare those rates to other data regarding the opioid epidemic, including the location
of overdose deaths. This information would help determine where additional resources may
need to be directed.
Recommendation: Write a letter to the Joint Standing Committee on Appropriations and
Financial Affairs expressing support for Sections 1 and 4 of LD 1429, An Act Regarding
the Epidemic of Opiate Abuse, which has been carried over on the appropriations table.
(Appendix X.)
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APPENDIX A

Authorizing legislation, Joint Order S.P. 210

SP0210,, 128th Maine State Legislature
Joint Order, Establishing the Task Force To Address the Opioid Crisis in the State

PLEASE NOTE: Legislative Information cannot perform research, provide legal
advice, or interpret Maine law. For legal assistance, please contact a qualified attorney.

Joint Order, Establishing the Task Force
To Address the Opioid Crisis in the State
ORDERED, the House concurring, that, notwithstanding Joint Rule 353, the Task Force To
Address the Opioid Crisis in the State, referred to in this order as "the task force," is established as follows.

1. Appointment; composition. The task force consists of members appointed as follows:
A. Four members of the Senate, appointed by the President of the Senate, including 2 members of
the party holding the largest and 2 members of the party holding the 2nd-largest number of seats
in the Senate;
B. Four members of the House of Representatives, appointed by the Speaker of the House, including
2 members of the party holding the largest and 2 members of the party holding the 2nd-largest
number of seats in the House of Representatives;
C. One member who is an administrator at a hospital in the State, appointed by the President of
the Senate;
D. One member representing the interests of law enforcement, appointed by the President of the
Senate;
E. One member representing the interests of providers of services at opioid treatment facilities,
appointed by the President of the Senate;
F. One member representing a statewide association of physicians in the State, appointed by the
President of the Senate;
G. One member who is recovering from opioid addiction, appointed by the Speaker of the House;

H. One member representing the interests of providers of substance abuse and recovery services,
appointed by the Speaker of the House;
I. One member who is a physician specializing in addiction treatment, appointed by the Speaker of
the House; and
J. One member who is a behavioral health specialist, appointed by the Speaker of the House.

The President of the Senate and the Speaker of the House shall invite to participate as members of the
task force the Governor, or the Governor's designee; the Attorney General, or the Attorney General's
designee; and a representative of the judicial branch.
2. Chairs. The first-named Senator is the Senate chair of the task force and the first-named member
of the House of Representatives is the House chair of the task force.

3. Appointments; convening. All appointments must be made no later than 30 days following
passage of this order. The appointing authorities shall notify the Executive Director of the Legislative
Council once all appointments have been made. When the appointment of all members has been
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Joint Order, Establishing the Task Force To Address the Opioid Crisis in the State

completed, the chairs of the task force shall call and convene the first meeting of the task force. If 30
days or more after the passage of this order a majority of but not all appointments have been made, the
chairs may request authority and the Legislative Council may grant authority for the task force to meet
and conduct its business.

4. Duties. The task force shall examine the current laws in the State addressing opiate abuse and
heroin use, including but not limited to existing laws focused on law enforcement, prevention, treatment
and recovery. As part of its study, the task force shall review the report and recommendations of the Maine
Opiate Collaborative issued on May 6, 2016 as well as initiatives that have been successfully undertaken
by other states, including but not limited to proposals for increased law enforcement personnel or funding;
substance abuse prevention, treatment and peer recovery services; and substance abuse prevention and
education in schools and communities, and shall develop recommendations to address the opioid crisis
in the State.
5. Compensation. The legislative members of the task force are entitled to receive the legislative per
diem, as defined in the Maine Revised Statutes, Title 3, section 2, and reimbursement for travel and other
necessary expenses related to their attendance at authorized meetings of the task force. Public members
not otherwise compensated by their employers or other entities that they represent are entitled to receive
reimbursement of necessary expenses and, upon a demonstration of financial hardship, a per diem equal
to the legislative per diem for their attendance at authorized meetings of the task force.
6. Quorum. A quorum is a majority of the members of the task force, including those members
invited to participate who have accepted the invitation to participate.
7. Staffing. The Legislative Council shall contract for necessary staff support for the task force
during the legislative session and may contract for such staff support for a longer period to the extent
needed and if sufficient funding is available. At the request of the task force, the Legislative Council may
provide drafting assistance to the task force during the legislative session and other staffing support to
the task force when the Legislature is not in session.
8. Reports. No later than April 30, 2017, the task force shall submit an initial report that includes
its findings and recommendations, including suggested legislation, for introduction to the First Regular
Session of the 128th Legislature. No later than December 6, 2017, the task force shall submit a final report
that includes its findings and recommendations, including suggested legislation, for introduction to the
Second Re~lar Session of the 128th Legislature.
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Department of Health
and Human Services
~
Safe, Healthy and Produdive Lives

Ricker HomiJJon, CommiS-5ioner

November 29, 2017

MEMORANDUM
TO:

Senator-Andre E. Cushing, III, Chair
Representative Joyce McCreight, Chair
and Members of the Opioid Task Force

FROM:

The Department of Health and Human Services (DHI-iS)

SUBJECT:

DHHS Narrative of Efforts to Address the State's Opioid Health Crisis

Affecting every state in the nation and now officially designated as a national public health
crisis, states are being hit with the devastating impacts of opioid addiction. Today, nearly half of
all U.S. overdose deaths involve a prescription opioid, with an estimated 91 Americans dying
every day from an opioid overdose. Last year in Maine, 376 people were reported to have died
from drug overdoses, a vast majority at the hands of opioids. The reach of this disorder affects
the lives of nearly every individual in Maine, and it is imperative that the administration, the
legislature, and the many statewide stakeholders take unified action to ·stop this crisis from
_escalating further. Protecting the lives of Mainers by tackling this opioid crisis head on is a top
priority for this Department. To ensure our efforts are effective, we have implemented a
multimodal approach, founded on evidence-based programs and initiatives aimed at supporting
the treatment and prevention of an opioid use disorder.
To combat the statewide opioid crisis at the root, DHHS has taken action in prioritizing effective
methods for the prevention and diversion of prescription drugs. In July of 2016, DHHS
successfully imple_mented the Chapter 488 Prescription Monitoring Law, which tightened the
limitations surrounding opioid prescriptions. The law restricts daily opioid prescription dosages,
outside of designated exemptions, to 100 morphine milligram equivalents (MME), limits the
opioid prescription duration to 7 days for acute pain and 30 days for chronic pain, and requires ·
prescribers review patients' prescription history in the Prescription Monitoring Program prior to
prescribing opioids. In an effort to effectively cover all areas of possible exploitation and
diversion, the law includes veterinarians in the definition of prescribers and requires mandatory
electronic prescribing of opioids as of July 1, 2017. Prescribers must also complete an additional
3 hours of education requirements through participation in opioid addiction training, which aids
our prevention efforts by ensuring providers are informed and equipped to offer the most
effective services. Since the law's installment, the Department has seen a 10 percent reduction in
Maine opioid prescriptions over the course of one year, translating to roughly 10 million fewer
doses of opioids in Maine communities.
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Additionally, we have dedicated $4.8 million toward the new Opioid Health Home (OHH)
initiative. The OHH program is a unique and innovative approach using evidence-based
treatment in providing an all-inclusive, team-based model of care for patients undergoing opioid
addiction treatment. Closely aligned with the Department's Behavioral Health Home model, the
primary care "health homes" are composed of a comprehensive group of providers supp01ting
individuals with whole-person care, which integrates physical, social, and emotional wellbeing in
addressing addiction. Services include substance abuse counseling, care coordination,
Medication-Assisted Treatment peer support, and medical consultation, all of which are offered
in a bundled rate with no fee-for-service.
In an effort to decrease the number of Maine babies born substance-exposed, we have developed
the screening tool SnuggleME for providers to reference when caring for pregnant women or
women of child-bearing age.
Snuggle:ME couples substance use education with traditional prenatal care by presenting care
providers with specific checklists and guidelines to follow when screening expectant mothers to
reduce prenatal exposure and enhance pregnancy outcomes. DHHS has also introduced new
reporting requirements for providers aiding in the treatment of opioid addicted pregnant women,
as well as new procedures integrating prenatal care and substance abuse treatment to help
pregnant women with substance use disorder achieve both long term recovery and a successful
and healthy child birth.
DHHS has worked hard to reduce barriers to treatment access through significant increases in
state resources directed toward substance use disorder treatment services for both Medicaid and
the uninsured. Funding has increased by 43 percent from $57 million to $82 million. In response
to the statewide opioid crisis, the Department has positioned the funding of its programs and
services to be person-centric, prioritizing direct funding at the individual level to ensure
accountability for measurable treatment outcomes.
The Depaitment has introduced changes to rules regarding methadone treatment administration
in accordance with an evidence-based model to ensure patients are receiving the most effective
treatment. These rule changes require that within 60 days of beginning treatment, providers
submit a formal plan of care to DHHS. This plan establishes specific goals and a treatment
baseline for each patient receiving methadone treatment. After 24 months of methadone
treatment, providers must then submit a prior authorization °form documenting the patient's
response to the treatment. Additionally, the new rules also require counseling be provided for
each member.
To address the impact substance use disorder has on families, the Department has focused efforts
toward programs for at-risk families in order to reduce substance abuse and improve competence
in Maine parents. Moving towards achieving these goals, DHHS is providing substance abuse
treatment and parenting education through the Matrix Model Intensive Outpatient Program and
the Positive Parenting Program (Triple-P), respectively. These programs work to:
•

Improve parental competence in managing common child behavior challenges and
developmental issues;

•
•
•

Decrease use of punitive methods to manage children's behavior;
Decrease parental stress and increase parental confidence; and
Reduce parental substance abuse during treatment.

Finally, DIIBS has also been working in collaboration with the Penobscot County Jail and
Penobscot Community Health Care to initiate a Vivitrol Pilot Project. Having launched this past
spring, the program -administers monthly Vivitrol injections to incarcerated women who have
volunteered to pa1ticipate. The injections sta1t two months prior to their release date and the
program offers services for continued counseling and housing assistance following discharge.
Vivitrol is the brand name ofNaltrexone and differs from other opioid use disorder treatments in
1'1 few ways. Vivitrol works as an opiate antagonist, blocking the brain's opioid receptors. Unlike
Suboxone and Methadone, Vivitrol cannot be used to get high. It also only requires a monthly
shot. Other treatment medications typically require a daily dose.
DHHS has been working tirelessly to develop comprehensive and effective strategies in
addressing the statewide opioid crisis. The Department has prioritized the critical areas of
prevention and harm reduction, treatment, and law enforcement at the forefront of the epidemic's
impact on Maine citizens. Our recent efforts have tightened prescription regulations, established
provider guidelines for methadone treatment and pregnancy screening, implemented new and '
innovative treatment programs, and have significantly increased state resources toward treatment
services. There is still work to be done, but if we continue with this comprehensive and unified
approach our efforts will help save the lives of hundreds of Mainers.

APPENDIXD
Department of Health and Human Services presentation on opioid health homes

Opioid Health Homes

· Paul R. LePage, Governor

Ricker Hamilton, Acting Commissioner
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Timeline
Spring 2017: Funding authorized
In spring 2017) the Maine Legislature passed legislation to allow for the implementation of
the OHH program.
April 2017: Emergency rule adopted
Recognizing the urgency ofthis issue, the OHH rule was adopted via emergency rulemaking
in April 2017, and the Department ofHealth and Human Services began accepting
applications from potential OHH providers. The first OHH provider was approved by the
end ofApril.
May 201 7: Public hearing held
In May, the Department held the public hearing for the permanent rulemaking, and based on
public comments) made significant changes to the program design prior to the rules final
adoption in July.
July 2017: Final rule adopted
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What it is
The OHH model is an innovative and evidence-based program that provides treatment
for MaineCare members and the uninsured who are struggling with opioid dependency.
It is a team-based model of care that focuses on treating the whole person through:

•
•

•
•

•

Substance abuse counseling
Care coordination
Medication-assisted Treatment (1,fAT)
Peer support
Medical consultation

Opioid Health Homes are comprised of a comprehensive group of providers that
furnish services based on an integrated care delivery model that is focused on wholeperson treatment. Through this model, individuals are provided with care that is
focused on their physical, social, and emotional wellbeing, instead of just their
addiction.

- -- - - - - - - - - - - - - -- - - - - -- - ---~-~--=-=~=-~~~=~=~===~--=· --=·=--·=----=
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Program Design

The OHH program is designed with-flexibility and accessibility in mind for the
providers and members. The OHH model is closely aligned with the Department's
Behavioral Health Home (BHH) model and shares similarities in the team design and
core standards.
Also like the BHH model, the payment rate is bundled; there is no fee-for-service.
There are two payment and program-design options for providers to choose from in
order to ensure maximum flexibility, allowing members to access medication in the
office or at local pharmacy.
Providers have access to their members' utilization data, which makes care
coordination more possible and effective.
With a rolling application process, providers may apply to become an OHH at any
point in time.
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•

Dispensing Medication: $1,000/P11PM

•

Prescribing Medication: $496/P:tv.1:PM

•

One (1) Section 93.05-7 office visit with the MAT
prescriber and member each month; AND

•

One (1) Section 93.05-7 office visit with the MAT
prescriber and member each month; AND

•

The OHH must provide adequate counseling to address
opioid substance use disorder. Section 93.05-8
counseling must be provided to each member at a
minimum of one (1) counseling session per month; AND

•

The OHH must provide adequate counseling to
address opioid substance use disorder. Section
93.05-8 counseling must be provided to each
member at a minimum of one (1) counseling
session per month; AND

•

Delivery of at least one additional covered service
described in Sections 93.05-1 through 93.05-6, to
an enrolled member within the reporting month,
pursuant to the member's Plan of Care/ITP.

Delivery of at least one additional covered service
described in Sections 93.05-1 through 93.05-6, to an
enrolled member within the reporting month, pursuant to
the member's Plan of Care/ITP.
•

Provision of a maximum of a thirty (30) day supply of
medication (Section 93.05-9); AND
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Opioid Health Home Team
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Team-Based Approach t<) Care
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Enhanced Access
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Eligibility & Accessibility

Any entity that meets the eligibility requirements·and core standards is allowed to
become an OHH. Providers can be, but are not limited to, mental health and substance
abuse agencies, including methadone clinics, FQHCs, or practices that are part of a
larger health system. To ensure maximum accessibility for members, care can be
provided anywhere, and can be customized to work in almost any setting.
Arrangements can look like:
•
•

A primary care office working with a local behavioral health agency
An FQCH providing all services under one roof

•
•

A methadone clinic
A behavioral health agency partnering with local MAT provider to provide services
in-house
Mobile services

•

7
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Eligibility & Accessibility

Opioid Health Home services are available for MaineCare members and the uninsured,
with identical eligibility criteria, core standards, and enrollment process.
OHHs serving the uninsured population must have access to HealthinfoNet to access
claims data. OHHs serving MaineCare members can access the Department's VMS
portal for claims data.
Like MaineCare members, uninsured individuals who receive Om-I services must have
a connection with a primary care provider, which they would receive through free care
rather than MaineCare coverage.

8
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Current Status
At this time, there are four approved OHH providers, with seven distinct sites. There
are an additional 16 applications in the approval process~
Providers vary from Federally Qualified Health Centers (FQHCs) to methadone clinics
and other substance abuse providers, to behavioral health providers.
The Department anticipates receiving applications from a number of primary care
providers who intend to provide OHH: as an integrated service, or partner with a
substance abuse provider.
·
The first OHH to begin serving MaineCare members is located in Calais and will begin
offering services in Octaber.
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APPENDIXE
Department of Health and Human Services September 27, 2017 answers to task force's
questions

Department of Health and Human Services
Commissioner's Office
221 State Street
11 State House Station .
Augusta, Maine 04333-0011
Poul R. lePoge, Governor

Tel. : (207) 287-3707; Fax: (207) 287-3005
m Users: Dial 711 (Maine Relay)

Ricker Hamilton, Acting Commissioner

September 27, 2017

MEMORANDUM
TO:

Senator Andre E. Cushing Ill, Senate Chair
Representative Joyce "Jay" Mccreight, House Chair
.Members, Task Force to Address the Opioid Crisis in the State

FROM:

Ricker Hamilton, Acting Commissioner

SUBJECT:

Answers from DHHS to the Opioid Task Force

1. What is the current estimate of how many individuals are in opioid use disorder treatment programs
in Maine? Please include a breakdown of those in methadone treatment, Suboxone, naltrexone,
residential treatment beds, intensive outpatient programs, detox beds, and other types of treatment
programs. (We understand that there are more Suboxone prescribers licensed to prescribe that
actual prescribers; we are interested in the number actually receiving Suboxone prescriptions and
services.)
Department's Response:

In SFY 18, SAM HS has $5.5 million available for MAT funding.
Number of licensed residential treatment beds: 174
Number of licensed intensive outpatient beds: 2,844
Number of licensed detox beds: 46
As reported on 9/18/2017, the following numbers represent active participants in treatment in Maine.
Methadone treatment: 3,872
Buprenorphine: 5,172
Naltrexone: 46

2. Please include any information available regarding payment source - MaineCare, insurance,
uninsured.
Department's Response:

Last Fiscal Year MaineCare spent over $20 million for opiate MAT funding and SAMHS spent $880,000
for MAT funding. This fiscal year, SAM HS has a $5.S million MAT budget, including $2 million for Opioid
Health Hol'T)es.
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3. What is the range of cost for residential treatment beds and detox beds?
4. Please provide any information available regarding the differing length of stay for residential beds.
Are there long term and short term beds?
Department's Response to questions 3 and 4:
Range of Costs Residential and Detox per OMS
Residential Type 1
219.78
Residential Type 2
117.17
Non-Hospital Based Detoxification
212.96
Adolescent Residential Rehabilitation
183.77
Halfway House Services
103.89
Extended Care Services
114.96
Personal Care {Shelter Services)
55.69
FMI on Services: See www.maine.gov LsoslcecLrulesL10Lch101.htm
Section 97

Per day
Per day
Per day
Per day
Per day
Per day
Per day

Residential Type I - MaineCare limits residential rehabilitation type 1 to thirty (30) days for any
single admission. with a limit of two (2) admissions and thirty (30) covered days on an annual
basis per member. These limits allow some clinical flexibility should additional treatment be
required or should a member drop out very early in treatment and are admitted at a later date.
Residential Rehabilitation Type II will provide a structured therapeutic environment for
members who are on a waiting list for treatment, or who have either completed detoxification
treatment, or are otherwise not in need of detoxification services. The primary objectives of
Residential Rehabilitation Type II are; to stabilize the substance abuser in order to provide
continuity of treatment, to enable the member to develop an appropriate supportive
environment, to remain substance free and to develop linkages with community services. The
term of residency shall not exceed forty-five (45) days.
Non-Hospital Based Detox - MaineCare limits non hospital based detoxification services to
seven (7) days for each admission episode, with no limit on the number of admissions or
covered days on an annual basis. The facility may provide detoxification services for a longer
period if medical necessity is substantiated and ordered by the medical director, and
documented in the member's clinical file by the facility's designated medical staff.
Adolescent residential rehabilitation PNMls provide the opportunity for recovery through
modalities, which emphasize personal growth through family and group support and
interaction. The PNM l's qualified staff shall teach attitudes, skills, and habits, conducive to
facilitating the member's transition back to the family and community. Adolescent residential
rehabilitation PNM ls are designed to last at least three (3) months and are limited to twelve (12)
months per single admission.
Halfway House - MaineCare limits halfway house services to a single admission of one hundred
eighty (180) covered days on an annual basis per member. Any stay in excess of one hundred
eighty /180) days requires documented need in the member's service plan.
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Extended Care - MaineCare limits extended care services to a single admission of two hundred
seventy (270) covered days on an annual basis per member. Any stay in excess of two hundred
seventy (270) days requires documented need in the member's treatment plan.
Personal Care Services - PNMls approved and funded by Adult Mental Health Services in
licensed facilities must also provide necessary personal care services for the promotio n of
ongoing treatment and recovery. MaineCare does not cover personal care services provided by
a family member.

5. Please provide any information available regarding specialty populations for residential beds, such as
pregnant women, women, adolescents, others?
Department's Response:

All residential treatment programs must prioritize clients as described above. W e provide funds to
Crossroads (15 bed) and Wellspring (10 bed) for pregnant and parenting woman and to Day One (27
beds} for adolescent s.
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6. Please provide a geographical breakdown of residential beds, intensive outpatient programs,
methadone treatment, suboxone, detox etc beds. The HHS committee received a chart during
work sessions on opioid use disorder bills with a breakdown by county- could this be updated
and broken down further within counties?

Substance Abuse Services Capacity per County
(llpd.ated May ?017)
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7. Please provide information on the Opioid Health Home initiative. How many OHHs have been

approved to provide services to those with substance use disorder? How many individuals are
receiving services through OHH? How many do you expect to be served? How many are being
served under MaineCare? How many slots are available for the uninsured? Please provide a
breakdown of how the $3.Sm funding in the supplemental budget is being spent?
Department's Response:
OHH presentation

8.

Please outline how the grants from the federal government through 21st Century CURES Act {$2m}
and Comprehensive Addiction and Recovery Act of 2016 are being spent.

Department's Response:
•

•
•

In July 2016, President Obama signed into law bipartisan Comprehensive Addiction and
Recovery Act (CARA). This legislation sought to advance evidence-based treatment and
prevention measures intended to reduce the rate of QPR and heroin misuse and
addiction. In December 2016, Congress enacted the 21st Century Cures Act (Cures Act), a
sweeping bill that included, among other things, reforms to the FDA approval process
and funding for cancer, Alzheimer's disease, and biomedical research. In particular, the
Cures Act also included several provisions intended to treat and prevent mental health
problems and to reduce the impact of SUD and opioid use disorders (DUD).
(5) Organizations will be providing MAT services utilizing the State Targeted Response
allocation of $1,614,457.00.
The remaining amount of this federal grant includes 15% allocated to Maine CDC and
5% for administration.

9. Please provide an update on the RFP for mental health peer centers. Also please provide information

on the current efforts of the department to provide recovery coaching services.
Department's Response:
•
(11) Contracts have been awarded for mental health peer recovery centers. These are
slated to begin 10/1/17.
• There are two additional RFPs in process right now: Substance Abuse Peer Support
Recovery Center, and Substance Abuse Peer Support Recovery Centers: Education,
Prevention and Coordination Services for which proposals have been received and are
currently being evaluated. Both RFPs contain components of activities associated with
recovery coaching services.
•
Peer Recovery Coaching has been built into Medicaid rule through Opioid Health
Homes.

10. Please provide information on the Snuggle ME contract. How much funding is allocated for the
program? How many are served?
Department's response: Snuggle ME is not a program, per se. Snuggle ME is a toolkit, or set of
guidelines, developed by the Department along with input from community stakeholders for healthcare
providers that work with pregnant women. It discusses universal screening for substance use disorders,
as well as information regarding treatment for women with substance use disorders and their infants.
Page 5 of 6

These guidelines are being updated currently, but the original version can be found at:
http://www.maine.gov/dhhs/mecdc/documents/SnuggleME-Project.pdf.
11. Is generic Suboxone covered by MaineCare?

Department's Response: Yes.
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APPENDIXF
Preliminary analysis of opioid treatment claims from the Maine Health Data Organization

Opioid Treatment- Preliminary Analysis

Pharmacy Claims -See the Methodology Tab for the details included in the Rx information below.

$464.65
2,412
29,716 $1,120,733.76
$512.73
1,718
21,270
$880,863.28
739
2,637
$93,827.73
$126.97
$93.80
525
4,936
$49,243.13
Notes: 2016 MHDO Commercial Pharmacy Claims. Total members with Pharmacy Claims: 475,331.
Buprenophine/Nalaxone
Suboxone
Natroxone
Methadone

Medical Claims -See the Methodology Tab for the details included in the inpatient and outpatient information below
Inpatient {Detox)
Outpatient
Detox (OP}

65
204
$643,418.01
410
15,540 $1,708,796.97
4
6
$9,584.52
Methadone Treatment
313
14,874
$789,844.85
Notes: 2016 MHDO Commercial Medical Claims. Total members with Medical claims: 457,143.

$9,898.74
$4,167.80
$2,396.13
$2,523.47

Produced 10/30/17
V.1 .0
Maine Health Data Organization
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For all of the analyses, 2016 commercial LOB was coded using the following codes:
Insurance Product Type Codes {Commercial)
12 Preferred Provider Organization (PPO)
13 Point of Service (POS)
14 EPO Plan
15 Indemnity Insurance
HM Health Maintenance Organization
Pharmacy Claims Analysis
For the
For the
For the
For the

buprenorphine analysis, all the codes from the "Buprenorphine" tab were included (list provided to MHDO).
suboxone analysis, all the codes that included "Suboxone" in the Prod Name column from the "Buprenorphine" tab were included (list provided
naltrexone analysis, all the codes from the "Naltrexone" tab were included {list provided to MHDO).
methadone analysis, we used the CDC Morphine Milligram Equivalent -found in the CDC compilation of benzodiazepines, muscle relaxants, stir

Medical Claims Analysis
For the inpatient analysis, the following codes were used:
Revenue Codes -Matches what is in the IP_Detox tab (list provided to MHDO)
0116 DETOX/PVT
0126 DETOX/SEMI-PVT
0136 DETOX/3&4BED
0140 ROOM-BOARD/DLX
0146 DETOX/DLXPVT
0156 DETOX/WARD
CPT/HCPCS
HZ2ZZZZ Detoxification Services for Substance Abuse Treatment (Non-OR)
Detox Subcategory
HZ2ZZZZ
0116 DETOX/PVT
0126 DETOX/SEMI-PVT
0136 DETOX/3&4BED
0146 DETOX/DLXPVT
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0156 DETOX/WARD

We included the following codes in the inpatient analysis overall and under the detox category
H0008 Alcohol and/or drug services; sub-acute detoxification (hospital inpatient)

H0009 Alcohol and/or drug services; acute detoxification (hospital inpatient)
H0010 Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)
H0011 Alcohol and/or drug services; acute detoxification {residential addiction program inpatient)
lC0-10 CM Codes (Rows 2-75 from the HCUP document)
For the outpatient analysis, the following codes were used:
CPT/HCPCS
H0012 Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)
H0013 Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)
H0014 Alcohol and/or drug services; ambulatory detoxification; Report this code for detoxification services for alcohol and drugs in which a provide1
H0015 Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is ba!
H0020 Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) (This includes the acqu
Jl230 Injection, methadone HCI, up to 10 mg
S0109 Methadone, oral, 5 mg
H0007 Alcohol and/or drug services; crisis intervention (outpatient)
H0016 Alcohol and/or drug services; med ical/somatic (medical intervention in ambulatory setting)
S9475 Ambulatory setting substance abuse treatment or detoxification services, per diem
Detox subcategory for Outpatient including the following codes.
H0012 Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)
H0013 Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)
H0014 Alcohol and/or drug services; ambulatory detoxification; Report this code for detoxification services for alcohol and drugs in which a provide1

Methadone subcategory
H0020
J1230
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ICD-10 CM Codes . Rows 2-75 from the HCUP document)

Final Note: The
information in this analysis
is a represenatative sample
of what is in the
commercial claims data
based on the methodology
described above. Due to a
federal rule that restricts
the submission of subtance
abuse disorder data to
States. There may be
claims data for the
treatment of substance
abuse disorders that has
notbeensubmittedtothe
MHDO. Although we think
the methodology used to
create this report is
comprehensive there may
be codes that are used to
classify a treatment
program that have not
been included in this
analysis.

···-•···-···~- •~

'' '''

"½-w>~.,."<"<·,r;r=,,.,;,'

~

' . ,;,

,. ,-

,. ·"' .<,.,.,.,~,,.............._, .......... ,..........,..,_.,_,,.,•. ,..~

,.,

'

• . --~··· "'"

.,,,."..,-~--~--,,~,_...,.,, --·-

............

...........,...~\--...,.,..,....._..,....,........,...J:'t"'~""'".._'"""'m=-·--------=-==- - - - - - - - - ---

I to MHDO}.
nulants, zolpidem, and opioid analgesics with oral morphine milligram equivalent conversion factors, 2017 version .

.,.,..,_"¥<•~

= •= <.,,:;:;:,,

<

v~v.~

,,:0,'.1)::;?(.t';.m<:,"7,:!~~~~f\\',\~¥.;l\i;J"~,

,. ..,__, ..........."""v.,«<»"""·'·"·••.n••i•

" , ,,,,

>

•'"·'""•••

"""

,.,.,.,.,.,._,•n.•>•,.,•._,,".,~-,•. •-•••~••.•

••• ••

'"

. , " f i $ ) l , ~ ~ . ,. . .,,,.

••H ••••••H••~-••·,•·,'>~•:;>,,'."-"'l"-'':-"t:1.-.,------------------------

r in an outpatient setting monitors mild to moderate symptoms associated with withdrawal from alcohol or drugs. Should there be a detox subca
sed on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education
isition and cost of the Methadone and administration)

r in an outpatient setting monitors mild to moderate symptoms associated with withdrawal from alcohol or drugs.
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APPENDIXG
Prescription Monitoring Program data on total prescriptions, patients and unique
prescribers of buprenorphine products

Aro-o~took,,_<.--

. wa1da"· :._
-..

· Prescriptions
20,854
. 7,760
32,742
3,013
7,647
22,407
14,722
7,513
8,675
19,417
1,891
3,864
8,017
6,086
6,774
19,194

Total Prescribers
Total Patients
Total Prescriptions

Patients Prescriptions Patients
1,426
1,359
17,795
720
7,301
645
3,293
28,537
3,040
226
2,863
265
623
8,144
594
19,223
1,637
1,541
831
893
15,716
552
6,994
543
8,723
680
756
1,552
1,655
18,840
135
1,699
139
3,381
316
308
654
8,758
708
6,871
479
469
552
6,815
585
1,559
1,623
17,105
1,091
892
15,294
15,064
190,576
178,765

*2017 data are preliminary and only include dispensations that occurred
from 1/1/2017 through 9/30/2017
**County is based on patient residence

S6Ura·. PMP
I

!

I

I[

l

I
I
I
I

APPENDIXH
Letter to the Department of Health and Human Services regarding the Snuggle ME
curriculum and the Maine Enhanced Parenting Project

Sen. Andre E. Cushing III, Chair
Sen. Scott W. Cyrway
Sen. Geoffrey M. Gratwick
Sen. James F. Dill
Steven Diaz
Katie Fullam Harris
Gordon H. Smith
Jeffrey Trafton
Robe1t Fowler
Vernon Gardner
Staff:
Anna Broome
Erin Lundberg

Rep . Joyce "Jay" McCreight, Chair
Rep. Karen Vachon
Rep. Anne Beebe-Center
Rep. Harold "Trey" L . Stewart III
Ross Hicks
Malo1y Shaughnessy
Hon. Janet T. Mills
Hon. William R. Stokes
Christopher Pezzullo

ST A TE OF MAINE
ONE HUNDRED AND TWENTY-EIGHTH LEGISLATURE

TASK FORCE TO ADDRESS THE OPIOID CRISIS IN THE STATE

December 12, 2017

Ricker Hamilton, Commissioner
Department of Health and Human Services
11 State House Station,
Augusta, Maine 04333-0011

Re:

Snuggle ME curriculum and Maine Enhanced Parenting Project

Dear Commissioner Hamilton,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210.
The Task Force applauds the work ofDHHS and other stakeholders in updating the
curriculum for the Snuggle ME program and we are hearing that the new version will be
disseminated to providers soon. As you know, Snuggle ME is a particularly effective screening
program that also provides treatment for women with substance use disorders and teaches skills
to parents of drug-affected babies. Our hope is that the Snuggle ME curriculum and other similar
programs are promoted as widely as possible to all providers who come into contact with these
populations.
The Task Force supports the expansion of the Maine Enhanced Parenting Project (MEPP)
to all families who could benefit from it. The MEPP is an evidence-based program combining
intensive outpatient treatment with the Positive Parenting Program (Triple P). The Triple Pis an
evidence-based program of intensive parent education intervention for families experiencing
moderate to severe behavioral or emotional difficulties.
The Task Force asks that the Department report the results its work and recommendations
regarding Snuggle ME and other similar programs and expansion of the MEPP by March 1, 2018
to the Joint Standing Committee on Health and Human Services.

December 12, 2017
Page2
Thank you for working on these important programs and we look forward to learning
more.
Sincerely,

,

J

~
h1. ,. ,
Sen. Andre E. Cushing
Senate Chair

cc:

<>¼B-~, c~ (i;:

G.J~/J::

"Jay" ~cCreight
House Chair

Members, Task Force to Address the Opioid Crisis in the State
Members, Joint Standing Committee on Health and Human Services

APPENDIX I
Letters to medical provider organizations regarding long-action reversible contraceptives

Sen. Andre E. Cushing III, Chair
Sen. Scott W. Cyrway
Sen. Geoffrey M. Gratwick
Sen. James F. Dill
Steven Diaz
Katie Fullam Harris
Gordon H. Smith
Jeffrey Trafton
Robe1t Fowler
Vernon Gardner
Staff:
Anna Broome
Erin Lundberg

Rep. Joyce "Jay" Mccreight, Chair
Rep. Karen Vachon
Rep. Anne Beebe-Center
Rep. Harold "Trey" L. Stewart lII
Ross Hicks
Malory Shaughnessy
Hon. Janet T. Mills
Hon. William R. Stokes
Christopher Pezzullo

STATE OF MAINE
ONE HUNDRED AND TWENTY-EIGHTH LEGISLATURE

TASK FORCE TO ADDRESS THE OPIOID CRISIS IN THE STATE
December 12, 201 7
Dr. Charles F. Pattavina, President
Maine Medical Association
P.O. Box 190
Manchester, ME 04351
Deai· Dr. Pattavina,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the I 28th Legislature by
Joint Order, S.P. 210.

An overarching goal for the task force is to reduce the number of drug-affected babies.
This includes preventing unplanned pregnancies for women at risk. One birth control strategy for
women with substance use disorders who wish to avoid an unplanned pregnancy is the use of a
long-acting reversible contraceptive (LARC) since they require less vigilance on the part of the
individual.
The Department of Health and Human Services recently amended the MaineCare
Benefits Manual, Chapter 45 (hospital services) to include reimbursement to providers for
inserting a LARC during a postpartum inpatient hospital stay, in addition to the existing
payments to hospitals for procedures relating to the birth. Women covered by MaineCare who
are in hospitals giving birth could be offered reproductive counseling while still in the hospital
and those options would include LARCs. We request that the Maine Medical Association
conducts outreach to its members through continuing medical education, rounds, newsletters, etc.
to ensure that they are aware of this benefit and offer it to women when it is appropriate. We
thank you for your attention to this important matter.
Since.rely,

•.,..,

/J

~~
Sen. Andre E. Cushir{g'III
Senate Chair
cc:

Members, Task Force to Address the Opioid Crisis in the State

Sen. Andre E. Cushing Ill, Chair
Sen. Scott W . Cyrway
Sen. Geoffrey M. Gratwick
Sen. James F. Dill
Steven Diaz
Katie Fullam Harris
Gordon H. Smith
Jeffrey Trafton
Robert Fowler
Vernon Gardner
Staff:
Anna Broome
Erin Lundberg

Rep. Joyce "Jay" Mccreight, Chair
Rep. Karen Vachon
Rep. Anne Beebe-Center
Rep. Harold "Trey" L. Stewai1 III
Ross Hicks
Malory Shaughnessy
Hon. Janet T. Mills
Hon. William R. Stokes
Christopher Pezzullo

STATE OF MAINE
ONE HUNDRED AND TWENTY-EIGHTH LEGISLATURE

TASK FORCE TO ADDRESS THE OPIOID CRISIS IN THE STATE
December 12, 2017
Pam Cahill, Executive Director
Maine Nurse Practitioners Association
1 Columbia Street
Augusta, ME 04330
Dear Ms. Cahill,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210.
An overarching goal for the task force is to reduce the number of drug-affected babies.
This includes preventing unplanned pregnancies for women at risk. One birth control strategy for
women with substance use disorders who wish to avoid an unplanned pregnancy is the use of a
long-acting reversible contraceptive (LARC) since they require less vigilance on the part of the
individual.
The Department of Health and Human Services recently amended the MaineCare
Benefits Manual, Chapter 45 (hospital services) to include reimbursement to providers for
inserting a LARC during a postpartum inpatient hospital stay, in addition to the existing
payments to hospitals for procedures relating to the birth. Women covered by MaineCare who
are in hospitals giving birth could be offered reproductive counseling while still in the hospital
and those options would include LARCs. We request that the Maine Medical Association
conducts outreach to its members through continuing medical education, rounds, newsletters, etc.
to ensure that they are aware of this benefit and offer it to women when it is appropriate. We
thank you for your attention to this important matter.

&

I Mf( ' ··.
ce "Jay"
hair
cc:
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Members, Task Force to Address the Opioid Crisis in the State

Sen. Andre E. Cushing Ill, Chair
Sen. Scott W. Cyrway
Sen. Geoffrey M. Gratwick
Sen. James F. Dill
Steven Diaz
Katie Fullam Harris
Gordon H. Smith
Jeffrey Trafton
Robert Fowler
Vernon Gardner
Staff:
Anna Broome
Erin Lundberg

Rep. Joyce "Jay" Mccreight, Chair
Rep. Karen Vachon
Rep. Anne Beebe-Center
Rep . Harold "Trey" L . Stewart III
Ross Hicks
Malory Shaughnessy
Hon. Janet T. Mills
Hon. William R. Stokes
Christopher Pezzullo

STATE OF MAINE
ONE HUNDRED AND TWENTY-EIGHTH LEGISLATURE

TASK FORCE TO ADDRESS THE OPIOID CRISIS IN THE STATE
December 12, 2017
Dr. Merideth C. Norris, President
Maine Osteopathic Association
128 State Street, Suite 102
Augusta, ME 04330
Dear Dr. Norris,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210.
An overarching goal for the task force is to reduce the number of drug-affected babies.
This includes preventing unplanned pregnancies for women at risk. One birth control strategy for
women with substance use disorders who wish to avoid an unplanned pregnancy is the use of a
long-acting reversible contraceptive (LARC) since they require less vigilance on the part of the
individual.
The Department of Health and Human Services recently amended the MaineCare
Benefits Manual, Chapter 45 (hospital services) to include reimbursement to providers for
inserting a LARC during a postpartum inpatient hospital stay, in addition to the existing
payments to hospitals for procedures relating to the birth. Women covered by MaineCare who
are in hospitals giving birth could be offered reproductive counseling while still in the hospital
and those options would include LARCs. We request that the Maine Medical Association
conducts outreach to its members through continuing medical education, rounds, newsletters, etc.
to ensure that they are aware of this benefit and offer it to women when it is appropriate. We
thank you for your attention to this important matter.
SincerelY,

,·~

/}

s~~~
Senate Chair

cc:
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/R~~Tyce ''Jay"(Jvi§reight

l!!ittse Chair

Members, Task Force to Address the Opioid Crisis in the State

APPENDIXJ
Resolve, Requiring the Maine Department of Education to Establish a Work Group
Regarding Drug Prevention Programs

Resolve, Requiring the Department of Education to Establish a Work Group
Regarding Drug Prevention Programs
Sec. 1. Department of Education to establish work group regarding drug
prevention programs. Resolved: That the Department of Education shall form a work group
to evaluate existing drug prevention programs targeting school-age children, investigate
programs that have proven effective in other areas of the U.S. or in other countries, identify
funding resources, and detennine how prevention programs are best incorporated into
educational cuniculum.
Sec. 2. Membership. Resolved: That the work group established in section 1 must
include representatives from the educational organizations including the Maine Education
Association, Maine School Management Association, Maine Principals Association and Maine
Interscholastic Athletic Administrators Association, representatives of law enforcement and
representatives of organizations that promote and facilitate programs focusing on public health,
drug prevention, and the welfare of children.
Sec. 3. Report. Resolved: That no later than January I, 2019, the Department of
Education shall report its findings including any recommended legislation to the joint standing
committee having jurisdiction over educational matters. The joint standing committee may
report out legislation based upon the report to the First Regular Session of the 129th Legislature.
SUMMARY

This resolve is a recommendation of the Task Force to Address the Opioid Crisis in the
State. It requires the Department of Education to establish a work group to evaluate existing
drug prevention programs targeting school-age children, investigate programs that have proven
effective outside of the State, identify funding resources, and determine how prevention
programs should be incorporated into the educational curriculum. The work group must include
representatives of educational, law enforcement and public health organizations. The report is
due no later than January 1, 2019 to the joint standing committee having jurisdiction over
educational matters.
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APPENDIXK
An Act To Implement the Recommendations of the Task Force to Address the
Opioid Crisis Regarding Respectful Language

An Act To Implement the Recommendations of the Task Force to Address the
Opioid Crisis Regarding Respectful Language

Emergency preamble. Whereas, Acts of the Legislature do not become effective until
90 days after adjournment unless enacted as emergencies; and
Whereas, treating a person with substance use disorder with respect, including in the
language that is used in referring to the person, to the system of delivering services and to the
services, offices and personnel of the Department of Health and Human Services is important to
the dignity of the person and to reducing stigma associated with having a disease and should be
accomplished at the earliest possible time; and
Whereas, in the judgment of the Legislature, these facts create an emergency within the
meaning of the Constitution of Maine and require the following legislation as immediately
necessary for the _preservation of the public peace, health and safety; now therefore,
Sec. 1. Revisor of Statutes to prepare legislation. Resolved: That the Revisor of
Statutes shall prepare legislation that amends all references to "substance abuse" in the Maine
Revised Statutes to read "substance use disorder'' no later than January 6, 2019. The legislation
shall be referred to the Joint Standing Committee having jurisdiction over health and human
services matters to be considered during the First Regular Session of the 129th Legislature; and
be it further
Sec. 2. Rename the Office of Substance Abuse and Mental Health Services.
Resolved: Notwithstanding any other provision oflaw, the Department of Health and Human
Services shall rename the Office of Substance Abuse and Mental Health Services using
respectful language; and be it further
Sec. 3. Department of Health and Human Services rules, forms, policies and
publications. Resolved: When adopting or amending its rules and developing, publishing and
issuing forms, policies and publications, the Department of Health and Human Services shall
replace references to "substance abuse" with references to "substance use disorder" and shall
ensure that language referring to persons with substance use disorders is consistent with
respectful language recommended in the final report of the Task Force to Address the Opiate
Crisis; and be it further
Sec. 4. Intent; effect. Resolved: This resolve is not intended to and does not change
the eligibility requirements for services or benefits or result in an expansion of services or
benefits provided by the Department of Health and Human Services·or impact eligibility or
requirements for federal programs and grants.
Sec. Emergency Clause. In view of the emergency cited in the preamble, this resolve
talces effect when approved.

SUMMARY
This resolve is a recommendation of the Task Force to Address the Opiate Crisis. It
requires the Revisor of Statutes to prepare legislation for the joint standing committee of the
Legislature having jurisdiction over health and human services matters to consider in the First
Regular Session of the 129th Legislature that amends the references to "substance abuse" to be
replaced with "substance use disorder". The changes in language are intended to be respectful
and minimize stigma for individuals who suffer with this disorder. There is no intention to
impact the state's ability to participate in federal policies, programs or grants.

APPENDIXL
Letter to the Drug Enforcement Administration requesting information on the National
Prescription Drug Take-Back Day in Maine
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Rep. Harold "Trey" L. Stewart III
Ross Hicks
Malory Shaughnessy
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STATE OF MAINE
ONE HUNDRED AND TWENTY-EIGHTH LEGISLATURE

TASK FORCE TO ADDRESS THE OPIOID CRISIS IN THE STATE
December 12, 2017
Michael W. Wardrop, Resident Agent in Charge
U.S. Drug Enforcement Administration
Portland ME Resident Office
1355 Congress St., Suite D
Portland, ME 04102

Re:

Drug Take-Back Programs

Dear Agent Wardrop,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210. We have heard from Sheriff Trafton from Waldo County, a member of the
Task Force, about the important work the Drug Enforcement Agency is doing with its biannual
National Prescription Drug Take-Back Day.
We are respectfully requesting that your agency provide information to the Joint Standing
Committee on Criminal Justice and Public Safety by March 1, 2018, about the successes of
National Prescription Drug Take-Back Day in Maine, including the amount of prescription drugs
collected; how the program is publicized; and whether your agency has investigated the use of
alternative drug disposal options, such as Deterra, as well as any other efforts of your agency to
reduce the availability of prescription drugs. We hope that you will encourage your law
enforcement and other partners to place additional take-back units in appropriate secure
facilities. Thank you for your all of your efforts to help reduce the availability of excess
prescription drugs .

. Andre E. Cushing
Senate Chair
cc:

Members, Task Force to Address the Opioid Crisis in the State
Members, Joint Standing Committee on Criminal Justice and Public Safety

APPENDIXM
Letter to the Maine Board of Pharmacy about the disposal of excess medications
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STATE OF MAINE
ONE HUNDRED AND TWENTY-EIGHTH LEGISLATURE

TASK FORCE TO ADDRESS THE OPIOID CRISIS IN THE STATE

December 12, 2017

Geraldine L. Betts, Administrator
Board of Pharmacy
35 State House Station
Augusta, ME 04333-0035

Re:

Drug Take-Back Programs

Dear Administrator Betts,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210.
In our work on the task force, we have heard about the importance of programs such as
the National Prescription Take-Back Day, to reducing availability of excess medications. We are
asking for your help to educate the public about how to dispose of excess medication safely by
requiring pharmacies to place a notice in an obvious place informing patients about local
disposal options. We believe that this would be one way to increase outreach to the public in
order to curb the availability of excess prescription drugs.
Thank you for your consideration of our request.

cc:

Anne Head, Commissioner, Department of Professional and Financial Regulation
Members, Task Force to Address the Opioid Crisis in the State

APPENDIXN
MaineHealth's hub and spoke treatment model

MaineHealth's Hub and Spoke Treatment Model
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APPENDIXO
Letter to the Department of Health and Human Services regarding hub and spoke
and opioid health home treatment models
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STATE OF MAINE
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Ricker Hamilton, Commissioner
Department of Health and Human Services
11 State House Station,
Augusta, Maine 04333-0011

Re:

Hub and spoke and opioid health home treatment models

Dear Commissioner Hamilton,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210.
We are requesting that the Department of Health and Human Services consider how the
hub and spoke model operated by MaineHealth and outlined in LD 1430, An Act To Develop a
Statewide Resource and Referral Center and Develop Hub-and-spoke Models To Improve
Access, Treatment and Recovery for Those with Substance Use Disorder, and other
evidence-based treatments might build on the opioid health home model under the current CMS
waiver. We are interested in funding integrated medication assisted treatment across the state,
creating integrated community-based relationships, and providing services of differing intensities
depending on the stage ofrecovery and needs of the individual.
The Task Force asks that the Department report the results its work and recommendations
by March 1, 2018 to the Joint Standing Committee on Health and Human Services. Thank you in
advance for considering these recommendations and we look forward to seeing the results of
your hard work.

'-. _/"-{ ~,-rv~~-c~~ ..l1~
Se . Andre E. Cushing
Senate Chair
cc:

/Rep/ Jd~e "Jay" Mctr-dght
Ho~se Chair
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Members, Joint Standing Committee on Health and Human Services
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December 14, 2017
Ricker Hamilton, Commissioner
Department of Health and Human Services
11 State House Station,
Augusta, Maine 04333-0011

Re:

Uninsured slots in opioid health homes and other treatment services

Dear Commissioner Hamilton,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210.
We are requesting that within its available resources the Department of Health and
Human Services immediately increase access to treatment across the state for patients, including
those who lack insurance or the means to pay, by increasing grant funds available to evidencebased programs that provide treatment to patients at varying levels of acuity. The task force is
grateful to Dr. Pezzullo for his suggestion to call the department when uninsured individuals are
unable to gain access to OHHs because slots are available. However, need for treatment is
critical and we should maximize the number of slots available.
We also request that the department examine the possibility of allowing access to
treatment services to minimum~security offenders in custody or in community release programs
or otherwise come into contact with law enforcement. There is a significant need for medicationassisted treatment services for individuals involved in the criminal justice system. In addition,
individuals moving into the community from the criminal justice system are particularly
vulnerable to accidental overdose. Connecting those individuals to services could save their
lives, help them reintegrate into the community and prevent recidivism. We applaud the efforts
of the department to fund slots for the uninsured. Could the Department consider extending some
of those uninsured slots to this population?
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The task force asks that the department report the results its work and recommendations
by March 1, 2018 to the Joint Standing Committee on Health and Human Services. Thank you in
advance for considering these recommendations and we look forward to seeing the results of
your hard work.

-~~~®
Sen. Andre E. Cushing
Senate Chair
cc:

Rep. Joyce "Jay" McCreight
House Chair

Members, Task Force to Address the Opioid Crisis in the State
Members, Joint Standing Committee on Health and Human Services
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November 28, 2017
Hon. Sara Gideon, Chair
Hon. Michael D. Thibodeau, Vice-Chair
Legislative Council
Maine State Legislature
115 State House Station
Augusta, ME 04333-0115
Dear Speaker Gideon and President Thibodeau,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State. The Task Force is
comprised of legislators and community experts in the fields of prevention, treatment and law enforcement, and
was created by the 1st Regular Session of the 128th Legislature by Joint Order, S.P. 210. On appeal before the
Legislative Council are bill requests on issues of importance to the Task Force.
During our work this year, the Task Force consistently heard that the lack of safe housing is a barrier to a
person's treatment and recovery from substance use disorder. As part of our recommendations to the
Legislature, we will be supporting the availability of stable housing for persons in recovery. Two bills
supporting recovery residences are currently before Legislative Council: (1) LR 2521, An Act to Ensure Quality
of and Increase Access to Recovery Residences (sponsored by Senator Bellows); and (2) LR 2744, An Act to
Save Lives and Create the Homeless Opioid User Service Engagement Pilot Project (sponsored by
Representative Gattine).
Additionally, the Task Force heard that access to treatment is critical to recovery and that more people can
access treatment when they have health insurance. LR 2755, An Act Regarding Health Care Ombudsman
Services (sponsored by Representative Vachon), currently before Legislative Council, would create an
ombudsman to help people complete an application with healthcare.gov to help them qualify for premium tax
credits and special enrollment and to obtain private health insurance outside of the regular enrollment period.
We are in support of the introduction of LR 2521, LR 2744, and LR 2755 addressing recovery housing and
access to health insurance in the Second Regular Session. Thank you for your consideration.
Sincerely,

&-£~

.

.

.

~~~ Al\)\.cc,~~

Se;, Andre E. Cushing~ t e Chair
Re£.J~~y"- McC~·ght,-ifouse Chair
cc:
Members, Task Force to Address the Opioid Crisis in the State
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STATE OF MAINE
ONE HUNDRED AND TWENTY-EIGHTH LEGISLATURE
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December 12, 2017
The Honorable Angus King
United States Senate
13 3 Hart Building
Washington, DC 20510

The Honorable Susan Collins
United States Senate
413 Dirksen Senate Office Building
Washington, DC 20510

The Honorable Chellie Pingree
United States House of Representatives
2162 Rayburn House Office Building
Washington, DC 20515

The Honorable Bruce Poliquin
United States House of Representatives
1208 Longworth House Office Building
Washington, DC 20515

Re:

Confidentiality provisions related to persons with substance use disorders

Dear Senators King and Collins and Representatives Poliquin and Pingree,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210. As part of our Final Report of recommendations, enclosed, we are writing
to you regarding the confidentiality restrictions for treatment providers of substance use
disorders in the hopes that you will work to amend the statute and regulations to allow for greater
information sharing across the continuum of care.
Federal law sets forth confidentiality requirements for records of patients with substance
use disorders. 42 U.S.C. § 290dd-2; 42 C.F.R. Part 2. These confidentiality requirements for
programs that provide treatment for substance use disorders are more restrictive than the Health
Insurance Portability and Accountability Act (IIlP AA). This creates significant challenges for
addressing the opioid crisis.
The confidentiality requirements limit the coordination of care between organizations
treating the patient and results in a :fragmented system along the continuum of care. Primary care
providers who are responsible for the "whole person" do not have ready access to important
information about some patients' health care conditions and needs, which adds to the stigma of
substance use disorders by treating them differently from every other medical condition. The
confidentiality requirement also means that records for persons with substance use disorders
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must be protected differently and shared differently, which requires cumbersome and expensive
workarounds in Electronic Health Records systems and contributes to higher healthcare costs for
patients with behavioral health needs.
We would be happy to answer any questions you may have about our request. Thank you
for your attention to this important issue.
Sincerely,

/Jt/1 ())~
~dre~
Senate Chair
Enclosures:

cc:
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/R~~Jofde "Jay" ~reight

'rfouse Chair
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Final Report of the Task Force to Address the Opioid Crisis in the State
Letter dated December 12, 2017 to U.S. DHHS, SAMHSA, and CMS

Members, Task Force to Address the Opioid Crisis in the State

Sen. Andre E. Cushing III, Chair
Sen. Scott W. Cyrway
Sen. Geoffrey M. Gratwick
Sen. James F. Dill
Steven Diaz
Katie Fullam Harris
Gordon H. Smith
Jeffrey Trafton
Robert Fowler
Vernon Gardner
Staff:
Anna Broome
Erin Lundberg

Rep. Joyce "Jay" Mccreight, Chair
Rep. Karen Vachon
Rep. Anne Beebe-Center
Rep. Harold "Trey" L. Stewart Ill
Ross Hicks
Malory Shaughnessy
Hon. Janet T. Mills
Hon. William R. Stokes
Christopher Pezzullo
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December 12, 2017

Eric D. Hargan, Acting Secretary
U.S. Dept. of Health and Human Services
200 Independence Avenue S.W.
Washington, D.C., 20201

Elinore F. McCance-Katz, Assistant Secretary
for Mental Health and Substance Use
Substance Abuse and Mental Health Services
Administration
5600 Fishers Lane
Rockville, MD 20857

The Honorable Seema Verma, Administrator
Centers for Medicare & Medicaid Services
U.S. Department of Health and Human
Services
Hubert H. Humphrey Building, Room 445-G
200 Independence Avenue, SW
Washington, DC 20201

Re:

42 C.F.R. Part 2

Dear Secretaries Hargan and Mccance-Katz and Administrator Verma,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210. As part of our Final Report of recommendations, enclosed, we are writing
to you regarding the confidentiality restrictions for treatment providers of substance use
disorders in the hopes that you will work to amend the statute and regulations to allow for greater
information sharing across the continuum of care.
Federal law sets forth confidentiality requirements for records of patients with substance
use disorders. 42 U.S.C. § 290dd-2; 42 C.F.R. Part 2. These confidentiality requirements for
programs that provide treatment for substance use disorders are more restrictive than the Health
Insurance Portability and Accountability Act (HIPAA). This creates significant challenges for
addressing the opioid crisis.
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First, the definition of patient under the federal regulations is expanded to include any
individual who has applied for or has been given a diagnosis or treatment of a substance use
disorder. 42 C.F.R. §§ 2.11. Organizations that receive federal alcohol and drug treatment funds
are restricted from even acknowledging that a person might have requested (not even received)
services from the program, unless a specific release is obtained from the client. Second, these
programs are required to obtain written patient authorization in advance of each and every
disclosure to other healthcare professionals, including information about treatment, payment, or
operations. 42 C.F.R. § 2.31. The confidentiality requirements limit the coordination of care
between organizations treating the patient and results in a :fragmented system along the
continuum of care. Primary care providers who are responsible for the "whole person" do not
have ready access to important information about some patients' health care conditions and
needs, which adds to the stigma of substance use disorders by treating them differently from
every other medical condition. The confidentiality requirement also means that records for
persons with substance use disorders must be protected differently and shared differently, which
requires cumbersome and expensive workarounds in Electronic Health Records systems and
contributes to higher healthcare costs for patients with behavioral health needs. Finally, these
programs are required to maintain a list of all disclosures made, 42 C.F.R. § 2. l3(d), requiring
programs to establish a tracking and reporting system and adding to the cost of the programs.
We would be happy to answer any questions you may have about our request. Thank you
for your attention to this important issue.
Sincerely,

.~ ~ , A l -

rv\S CmJ<~

~ L . .C--t,u:::-s-thin.A'
r,g...,,7t1,~~

td, J~~ ~'Jay" Mc~ight

Senate Chair

House Chair
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John Gallagher, Director
Maine State Housing Authority
353 Water Street
Augusta, ME 04330

Re:

Work group on recovery residences

Dear Mr. Gallagher,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210. We are writing to you in support of the development of recovery housing
in Maine and are asking for your help.
We are requesting that your agency convene a work group to develop a certification
process for recovery housing that is consistent with the standards of the Maine Association of
Recovery Residences to serve people in recovery, including those who are engaged in integrated
medication-assisted treatment. We are also requesting that this work group investigate and make
recommendations regarding available funding resources and development opportunities. The
work group should include Maine's Department of Health and Human Services, Finance
Authority of Maine, Maine Real Estate and Development Association, Maine Association of
Recovery Residences and representatives of treatment providers, housing services, affordable
housing developers, the recove1y community, and persons experiencing homeless.
The task force asks that the work group report the result its work and recommendations
beginning March 1, 2018, and then quarterly for one year, to the Joint Standing Committees on
Labor, Commerce, Research, and Economic Development and Health and Human Services.
Thank you in advance for your efforts in organizing this work group and we look forward to
seeing the results of your hard work.

s~·nceely,

~

*

C
~l(_l

S n. Andre E. Cus ·
Senate Chair
cc:
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Ricker Hamilton, Commissioner
Department of Health and Human Services
11 State House Station,
Augusta, Maine 04333-0011

Re:

Centralized database of treatment resources

Dear Commissioner Hamilton,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 12 8th Legislature by
Joint Order, S.P. 210.
The task force identified that often people do not know where to go to receive
information on services and that information that is available on services available is often
inaccurate. This creates a barrier for people with substance use disorders to access treatment.
We are requesting that the Department of Health and Human Services evaluate the options for
developing a database of available treatment services, including what information the database
would contain; whether it could include real-time data and the usefulness of that data; how to
accurately identify provider capacity and waitlists; how much it would cost; and how it could be
implemented and funded, including whether legislation would be required to implement the
database.
The task force asks that the department report the results its work and recommendations
by March 1, 2018 to the Joint Standing Committee on Health and Human Services. Thank you
in advance for considering these recommendations and we look forward to seeing the results of
your hard work.
S1·_ncerel/ /

/1~
- ;J

/~~~

.
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,

A~V\__C(rt.·Cf\_;\

e . '.Andre E. Cushingafr
R4-,J&yclfray" Mct~ht
Senate Chair
House Chair
cc:
Members, Task Force to Address the Opioid Crisis in the State
Members, Joint Standing Committee on Health and Human Services
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December 12, 2017
Nikki Busmanis
2-1 -1 Maine Program Manager
United Way of Mid-Maine
105 Kennedy Memorial Drive
Waterville, ME 04901

Re:

Improvements to 2-1-1

Dear Ms. Busmanis,
We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210. Thank you for presenting to our task force on November 28, 2017 about
your program's ongoing efforts to improve the 2-1-1 service.
We are requesting that your program continue to identify areas for improvement and
implement those changes to the 2-1-1 service in relation to substance use disorder, including the
accuracy and ease of accessibility of the website and database; staff training; outreach to
providers who are not licensed by the State; and plans for public awareness of 2-1-1 services,
including alternative platforms to access information.
The task force asks that you report the results your work by March 1, 2018 to the Joint
Standing Committee on Health and Human Services. Thank you in advance for your efforts to
work toward improving access to information about treatment resources for substance use
disorders and we look forward to seeing the results of your hard work.

c_}Jf'-V\1'J-! (r-ff;iJ_
~ p . Joyce "Jay" ~cCreight
House Chair
- , _)
cc:

Members, Task Force to Address the Opioid Crisis in the State
Members, Joint Standing Committee on Health and Human Services

APPENDIXV
Substance abuse treatment programs in the state prison system

Substance Abuse Treatment Programs in the State Prison System
Associate Commissioner Ryan Thornell, Ph.D.
Revised 2.2.2017
The Maine Department of Corrections (DOC) offers substance abuse treatment programs at all of its
secure adult facilities, including the Maine State Prison (MSP), Maine Correctional Center (MCC),
Mountain View Correctional Facility (MVCF), and Women's Center (WC). Additionally, programs are
offered at the Bolduc Correctional Facility (BCF} and Women's Reentry Center (WRC). The Department
partners with Correct Care Solutions (CCS) and Day One to provide these services.
•
As of July 2012, MDOC entered into a contract with Correct Care Solutions to provide both
medical and behavioral health services to the adult an~ juvenile populations. In July 2015,
Correct Care Solutions began providing substance abuse treatment services across the
Department's adult facilities. The substance abuse treatment services provided by Correct Care
Solutions are paid for by the DOC (general funds), with support from the DHHS SAM HS Office
(general funds).
•
Also in July 2015, the juvenile facility at Mountain View was repurposed into a secure adult
correctional facility focused on providing treatment programs to male prisoners. Day One, the
previous provider of juvenile substance abuse treatment services at this location, was retained
and began offering the substance abuse treatment services at the Mountain View Correctional
Facility,· including the Substance Abuse Unit. The SE;rvices provided by Day One _are paid for by
the DHHS SAM HS Office.

Substance Abuse Trea~ment ~eed
•

•

•

•

•

•
•

In 2016,the number of new male admissions into the DOC on new sentences·for drug crimes
accounted for 31% of the year's total admissions (201 new drug admissions). This number of
new admissions is an increase of 37% from the year 2015 (147 new admissions), and an increase .
of 53% from the year 2014 (131 new admissions).
In 2016, the number of new female admissions into the DOC on sentences for drug crimes
accounted for 41% of the year's total admissions (39 new drug admissions). This number of new
admissions is an increase of 18% from the year 2015 (33 new admissions}, and an increase of
56% from the year 2014 (25 new admissions).
Upon admission into the DOC, male and female offenders are screened, and if necessary, further
assessed to identify their level of substance abuse treatment need . In 2016, 1,188 offenders
were screened and/or assessed .
In 2016, the male prisoners admitted into the Department's institutions were assessed as having
the following substance abuse treatment need:
o 48% were assessed as needing outpatient substance abuse treatment;
o 19% were assessed as needing residential s~bstance abuse treatment;
o 33% were assessed as not needing substance abuse treatment; ·
In 2016, the female prisoners admitted into the Department's institutions were assessed as
having the following substance abuse treatment need:
o 88% were assessed as needing outpatient substance abuse treatment;
o 1% were assessed as needing residential substance abuse treatment;
o 11% were assessed as not needing substance abuse treatment;
The Department has two residential substance abuse treatment programs for male prisoners,
the Correctional Recovery Center at MCC and the Substance Abuse Unit at MVCF.
The remaining treatment programs offered across the facilities are outpatient substance abuse
programs.

Residential Substance Abuse programs
• The Correctional Recovery Center (MCC) is a 12 month residential substance abuse treatment program,
provided by Correct Care Solutions, that has the goal of reducing prisoner's dependency on drugs and
alcohol. The Correctional Recovery Center utilizes a therapeutic community structure, which emphasizes
routine, structure, and peer-accountability. Upon completion of the program, prisoners either
transfer to a minimum security facility or are released to the community. Across the last 18
months, this program has graduated 55 prisoners.
• The Substance Abuse Unit (MVCF) opened in July 2015 and is a 12 month residential substance
abuse treatment program, provided by Day One, focused on reducing prisoner's dependency on
drugs ·and alcohol. This unit utilizes a modified-therapeutic community structure, which
emphasizes routine, structure, and peer-accountability. Upori completion of the program,
prisoners either transfer to a minimum security facility or are released to the community. Since
it opened, this program has graduated 54 prisoners.
_
•
At the end of 2016, approximately 150 male prisoners remained on the Department's "waitlist"
for residential substance abuse treatment.
Outpatient Substance Abuse programs
•
The Department offers evidence-based outpatient substance abuse programming at all of its
adult facilities (excluding Downeast Correctional Facility}. These programs are delivered by
Correct Care Solutions. - •
The primary outpatient substance abuse program utilized is Cognitive .Behavioral Interventions·
for Substance Abuse, a curriculum developed by the University of Cincinnati Corrections
Institute. This program is approximately six (6) months in duratio_n.
•
The Department offers other outpatient substance abuse programs to both male and female
prisoners. Seeking Safety is an outpatient program that addresses both trauma and substance
abuse, and may be offered to male and female prisoners. At the female facilities, Co-Dependent .
No ivrore is also offered.
• - At the minimum security facilities (excluding Downeast Correctional Facility), Living in Balance is
also offered to address substance abuse treatment needs in a more flexible manner. Thisopenenrollment curriculum is focused on substance abuse recovery and is able to be individualized
based upon the prisoner's substance abuse treatment needs, allowing for the flexibility needed
at a minimum security facility. The program has up-to 47 different program lessons to be
included in the program delivery.
•
In 2016, 518 male prisoners and 181 female prisoners successfully completed outpatient
substance abuse treatment while incarcerated.
• At the e_nd of 2016, 540 m_ale prisoners remained on the Department's "waitlist" for outpatient
substance abuse treatment.
• At the end of 2016, 55 female prisoners remained on the Department's "waitlist'' for outpatient
substance abuse treatment.

APPENDIXW
An Act to Establish the State Coordinating Council on Corrections Practices Relating to
Substance Use Treatment Programs

An Act to Establish the State Coordinating Council on Corrections Practices
Relating to Substance Use Treatment Programs
Sec. 1. 5 MRSA § 12004-I, sub-§ 4-D is enacted to read:

Corrections

State Coordinating
Council on
Corrections Practices
Relating to Substance
Use Treatment
Programs

Expenses Only

34-A MRSA § 1209-

_c

Sec. 2. 34-A MRSA § 1209-C is enacted to read:
§ 1209-C. State Coordinating Council on Corrections Practices Relating to Substance Use
Treatment Programs

!,

Definitions. As used in this section, unless the context otherwise indicates, the
following terms have the following meanings.

A. "Person with a substance use disorder" has the same meaning as the terms
"alcoholic," "drug abuser," "drug addict," and "drug-dependent person" in Title 5 section
20003.
B. "Treatment» has the same meaning as the term "treatment" in Title 5 section 20003. '
C. "Treatment program" has the same meaning as the term "treatment program" in Title 5
section 20003.
2. Council established. The State Coordinating Council on Corrections Practices Relating
to Substance Use Treatment Programs, established in Title 5, section 12004-I, subsection 4-D
and referred to in this section as "the council, 11 is created for the purpose of conducting
continuous study and coordination of corrections practices related to persons with substance use
disorder in jails and correctional facilities. The council shall promote and implement the most
effective evidence-based modalities in order to support the treatment and recovery of persons
with substance use disorder.
~- Membership. The council is composed of the following members:

A. The commissioner or the commissioner's designee and 2 state corrections officials
designated by the commissioner, one of whom is from Adult Community Corrections:
;B_. The Commissioner of Public Safety or the commissioner's designee;
Q. A representative of a statewide association of county commissioners nominated by the

association and appointed by the Governor;
D. A representative of a statewide association of county sheriffs nominated by the
association and appointed by the Governor:
E_. A representative of a statewide association of county jails nominated by the association
and a1wointed by the Governor:
E_. A representative of a statewide association of prosecutors nominated by the association
and appointed by the Governor:

G. A representative of a statewide association of criminal defense attorneys nominated by
the association and appointed by the Governor:
H. A representative of a statewide municipal association nominated by the association and
appointed by the Governor;

I.

The Commissioner of the Department of Health and Human Services or the
commissioner1s designee:

J.

A representative from a community-based organization with experience working with
persons in recovery and persons transitioning out of the criminal justice system;
K. A representative from a provider organization that treats persons with substance use
disorder using evidence-based practices, such as integrated Medication Assisted Treatment.
The Governor also shall ask the Chief Justice of the Supreme Judicial Court to serve as or to
name a designee to serve as a member of the council and to appoint one trial judge or another
designee to serve as a member of the council.

J.. Chair; terms; vacancies. The Governor shall appoint a member to serve as chair.
Members of the council serve for terms of 2 years and may be reappointed. If a member cannot
serve for any reason, the vacancy for the member1s unexpired term must be filled by the
appointing authority.
1,. Meetings. The council shall meet at least 4 times a year and keep minutes and records
of the meetings.
~- Duties. The council shall coordinate criminal justice information and collaborate with
persons who work in the criminal justice and treatment fields. Specifically, the council shall:
A. Advise the Department of Corrections and county or regional jails on the treatment
programs and rehabilitation needs that would best serve the needs of offenders and pretrial
defendants:
B. Evaluate on an ongoing basis existing treatment programs and rehabilitation services

available to offenders and pretrial defendants:
Q. Develop recommended evidence-based correctional practices and services for managing
the treatment and rehabilitation needs of offenders and pretrial defendants:
D. Promote, support, and implement the use of the recommended evidence-based
correctional practices and services for managing the treatment and rehabilitation needs of
offenders and pretrial defendants;

:E.

Provide information and assistance to county and state corrections officials regarding
current evidence-based correctional practices and services for managing the treatment and
rehabilitation needs of offenders and pretrial defendants and provide a forum for sharing
information on evidence-based practices and services that are used throughout the State: and

,E. Review laws and policies and monitor proposed legislation and policies that affect the ·
state and county criminal justice and correctional systems relating to substance use
treatment and make recommendations to the legislative, executive and judicial branches
regarding these proposals.

§_; Report.

At the beginning of the first regular session of each Legislature and no later
than January 15th, the council shall submit a report to the joint standing committee of the
Legislature having jurisdiction over criminal justice and public safety matters and to the
Governor. The report must include recommendations and any necessary implementing
legislation with respect to matters related to the council1s duties and accomplishments, including
recommendations on state compliance.

7..

Departmental duties and powers.
regard to this section are as follows.

The duties and powers of the department with

A. The department shall serve as the fiscal agent of the council.
B. The department may accept funds from the Federal Government, from any political
subdivision of the State or from any individual, foundation or corporation and may expend
those funds for pm:poses consistent with this section.
C. The department shall provide technical assistance to counties and criminal justice
planning committees, as established in Title 30-A, section 1671, to aid them in the planning
and development of community corrections.

~- Funds not to lapse. Funds awropriated to carry out the purposes of this section do not
lapse but must be carried forward from year to year.

,2. Reimbursement of expenses. The members of the council must be compensated
according to the provisions of Title 5, chapter 379.

SUMMARY
This bill establishes the State Coordinating Council on Corrections Practices Relating to
Substance Use Treatment Programs. The council is to study, evaluate, and promote
evidence-based treatment programs to support the recovery of persons with substance use
disorder. It identifies the membership of the council, the number of meetings, the duties, and the
reporting requirements of the council.
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STATE OF MAINE
ONE HUNDRED AND TWENTY-EIGHTH LEGISLATURE

TASK FORCE TO ADDRESS THE OPIOID CRISIS IN THE STATE

TO:

James M. Hamper, Senate Chair
Drew Gattine, House Chair
Joint Standing Committee on Appropriations and Financial Affairs

FROM:

Andre E. Cushing III, Senate Chair
c...,ti1,
Joyce "Jay" McCreight, House Chai --~
Task Force to Address the Opioid C' ·sis in the State of Maine

DATE:

December 12, 2017

RE:

LD 1429, An Act Regarding the Epidemic of Opiate Abuse

i-

We are writing on behalf of the Task Force to Address the Opioid Crisis in the State of
Maine, which consists of legislators and community experts in the fields of prevention, treatment
and law enforcement, and was created by the First Regular Session of the 128th Legislature by
Joint Order, S.P. 210. We are in support of Sections 1 and 4 of LD 1429, An Act Regarding the
Epidemic of Opiate Abuse, which has been carried over on the appropriations table. The Task
Force takes no position on Sections 2 and 3.
Section 1 would allow flexibility in distributing funds received from civil forfeitures.
The agency that made a substantial contribution to the investigation or prosecution of a criminal
case could request that the funds be redirected to a law enforcement agency in Maine that
provides case management and other social services to persons with substance use disorders.
The ability to direct funds to support the treatment needs of persons with substance use disorders
would be a critical component of addressing the opioid crisis in the State.
Section 4 would allow certain aggregate data to be reported from the prescription
monitoring program that would allow policy makers to see trends in prescribing rates and
compare those rates to other data regarding the opioid epidemic, including the location of
overdose deaths. This information would help determine where additional resources may need to
be directed.
Thank you for your consideration of our recommendations.

128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
No.1429

Legislative Document
H.P. 983

House of Representatives, April 13, 2017
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Clerk
Presented by Representative GROHMAN of Biddeford.
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1

Be it enacted by the People of the State of Maine as follows:

2
3

amended to read:

4
5

Sec. 1. 15 MRSA §5826, sub-§6, as amended by PL 1999, c. 408, §3, is further

17
18

6. Final order of disposition of property; public education campaign. Following
the entry of a verdict of forfeiture of property pursuant to this section or the entry of a
guilty plea in open court on the record and following the court's disposition of all
petitions for hearing timely filed by 3rd parties, the State has clear title t-0 property that is
the subject of the indictment, information or co:r;nplaint. The final order must provide for
the deposit of the property or the proceeds from the disposition of the property, less the
reasonable expenses of the forfeiture proceedings, seizure, storage, maintenance of
custody, advertising and notice, in the General Fund, except that, to the extent that the
court finds it reasonable, the court may ord~r forfeiture of as much of the property as is
appropriate, less the reasonable expenses of the forfeiture proceedings, seizure, storage,
maintenance of custody, advertising and notice, to a municipality, county or state agency
that has made a substantial contribution to the investigation or prosecution of a related
criminal case or, uponreguest of the investigating agency or the prosecuting agency, to a
law enforcement agency in this State that provides case management and other social
services to persons with substance use disorders.

19
20

amended to read:

6
7

8
9
10
11
12
13

14
15

16

21
22
23
24
25

26
27
28
29
30
31

32
33

Sec. 2. 17-A :MR.SA §1105-B, sub-§1, ~, as enacted by PL 2003, c. 476, §5, is
·

D. Death or serious bodily injury of another person is in fact caused by the use of
that eeootefi'eit drug one or more drugs and the drug furnished by the defendant is a
contributing factor to the death or serious bodily injury of the other person.

Sec. 3. 17-A :MR.SA §1105-C, sub-§1, 1K, as enacted by PL 2003, c. 476, §7, is
amended to read:

K.

Death of another person is in fact caused by the use of that seheElw.ed drug one
or more drugs and the drug is a seheewe W drug furnished by the defendant is a
contributing factor to the death of the other person. A violation of this paragraph is a
Class B crime. It is an affirmative defense to prosecution under this paragraph that
the drug furnished was lawfully possessed by the defendant prior to furnishing and
that the de1,1.th was not a reasonably foreseeable consequence of the use of that
scheduled drug. In determining whether the death was reasonably foreseeable, the
jury shall consider:
·

34

(1) The factual circumstances surrounding the furnishing or'the drug;

35

(2) The total quantity of the drug furnished;

36

(3) The dosage of the units furnished;

37

(4) The nature of the drug;

38

(5) The overdose ri~ presented by use of the d!t1g; and

39

(6) Any safety WarJ¥figs provided to the defendant at the time of dispensing the
drug; or

40
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1

Sec. 4. 22 MRSA §7250, sub-§7 is enacted to read:

2
3
4
5
6
7
8
9
10
11
12

7. Report regarding program. The department shall provide to the joint standing
committee of the Legislature having jurisdiction over health and human services matters
on or before January 15th of each year. and at such other times as the committee requests.
data pertaining to the aggregate number of prescriptions of each drug required to be
included in the program. the number of prescribers participating in the program
categorized by specialty, any historical trends or patterns in prescribing Dractices within
the State. any progress in the implementation of information sharing agreements
authorized by subsection 4-A and any other information pertaining to the work of the
program as requested by the committee that is reasonably available to the department. as
long as all information reasonably likely to reveal the· patient or the prescriber or other
person who is the subject of the information has been removed.

13

SUMMARY

14

This bill addresses the opiate crisis in Maine by:

15
16
17
18

1. Allowing funds from property forfeited pursuant to a criminal forfeiture action to
be assigned by the court, upon the request of the investigating or prosecuting agency, to a
law enforcement agency in this State that provides case management and other social
services to persons with substance use disorders;

19
20
21

2. Clarifying that the Class B crimes of aggravated furnishing of scheduled drugs and
aggravated trafficking or furnishing of counterfeit drugs are for the death of another
person, whose death was caused by drugs furnished by the defendant; and

22
23
24
25
26

3. Requiring the Department of Health and Human Servjces to provide an annuai
report to the joint standing committee of the Legislature having jurisdiction over health
and human services matters regarding the Contro]J.ed Substances Prescription Monitoring
Program, in.eluding the number of prescribers participating and ,trends in. prescription
practices.
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2

3
4

L.D.1429
(Filing No. H-

Date:

)

CRIMINAL JUSTICE AND PUBLIC SAFETY
Reproduced and distributed under the direction of the Clerk of the House.

5

STATE OF MAINE

6

7

HOUSE OF REPRESENTATIVES
128TH LEGISLATURE

8

FIRST REGULAR SESSION

9
10

COMMITTEE AMENDMENT "
" to H.P. 983, L.D. 1429, Bill, "An Act
Regarding the Epidemic of Opiate Abuse"

11
12

13

Amend the bill by inserting after section 1 the following:

'Sec. 1. 17-A MRSA §1105-A, sub-§1, 1~ and L, as enacted by PL 2003, c.
476, §2, are am.ended to read:

14
15
16
17

K. Death of another person is in fact caused by the use of that seheawed drag one or
more scheduled drugs the scheduled drug trafficked by the defendant is a
contributing factor to the death of the other person and the drug is a schedule W drug.
A violation of this paragraph is a Class A crime; or

18
19
20
21

L. Serious bodily injury of another person is in fact caused by the use of that
sehedwed drug one or more scheduled drugs, the scheduled drug trafficked by the
defendant is a contributing factor to the serious bodily injury of the other person and
the drug is a schedule W drug. A violation of this paragraph is a Class B crime.'

22

Amend the bill by adding after section 4 the following:

'Sec. 5. Appropriations and allocations. The following appropriations and

23
24

allocations are made.

25

INDIGENT ~EGAL SERVICES, MAINE COMMISSION ON

26

Maine Commission on Indigent Legal Services Zl12

27
28

Initiative: Provides funds for an anticipated increase in indigent legal services costs
resulting from additional prosecutions involving death or serious bodily injury to a
person.

29
30
31
32

GENERAL FUND
All Other

2017-18

$8,250
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COMMITTEE AMENDMENT

2018-19
$11,000

COMMITIEE AMENDMENT"

1

"to H.P. 983, L.D. 1429

GENERAL FUND TOTAL

$8,250

$11,000

2

3
4

A.mend the bill by relettering or renumbering any nonconsecutive Part letter or
section number to read consecutively.

5

SUMMARY

6
7
8
9
10

This '1,mendment adds to the bill new variants of aggravated trafficking of scheduled
drugs that includes trafficking in scheduled drugs when the trafficked scheduled drug was

a contributing factor in the death of another person, a Class A crime, or serious. bodily
injury of another person, a Class B crime.
The amendment also adds an appropriations and allocations section.

11

FISCAL NOTE REQUIRED

12

(See attached)
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COMMITTEE AMENDMENT

Approved: 06/05/17 ~ae!.

128th MAINE LEGISLATURE
LR666(02)

LD 1429

An Act Regarding the Epidemic of Opiate Abuse

Fiscal Note for Bill as Amended by Committee Amendment 11
Committee: Criminal Justice and Public Safety
Fiscal Note Required: Yes

"

Fiscal Note
Potential current biennium revenue decrease - General Fund
Potential current biennium revenue increase - Municipal ~d County Law Enforcement

FY 2017-18

FY2018-19

Projections

Projections

FY2019-20

FY2020-21

Net Cost (Savings)

General Fund

$8,250

$11,000

$11,000

$11,000

$8,250

$11,000

$11,000

$11,000

Appropriations/Allocations

General Fund

Correctional and Judicial Impact Statements
Establishes new Class A and Class B crimes, increases correctional ·an.djudicial costs.
The collection of additional fines may also increase General Fund revenue by mino~ amounts.
Fiscal Detail and Notes

The bill includes General Fund appropriations of$8,250 in fiscal year 2017-18 and $11,000 in fiscal year 2018-19 for
the Maine Comroission on Indigent Legal Services to support the anticipated increase in costs resulting from
additional prosecutions involving death or serious bodily injury to a person.
Under current statute, the court determines the disposition of forfeited property and may order it deposited to the
General Fund or that it go to a municipality, ·county, or state agency that has made a substantial contribution to the
investigation or prosecution of a related criminal case. This bill keeps that language and adds to the court's options by
also allowing disposition of forfeited property to, upon request of the investigating agency or prosecuting agency, a
law enforcement agency in this State that provides case management and other social services to persons with
substance use disorders. In any future case where the court will opt to use the new provision to redirect forfeited
property from the General Fund to a local law enforcement agency, revenue will be increased to the receiving agency
and reduced to the General Fund. No estimate of the amounts redirected can be made at this time.
Any additional costs to the Department of Health and Human Services from the provisions of this bill are expected to

be minor and can be absorbed within existing budgeted resources.
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APPENDIXY
Descriptions of medications used to treat opioid use disorder

Buprenorphine
Buprenorphine [aka Suboxone] , which is a partial opioid agonist, is used to treat someone who is
addicted to an opioid -whether the substance being abused is heroin or a prescription painkiller, such
as OxyContin or Vicodin. Of the few medications used for opioid dependence, buprenorphine is the first
that can be prescribed for and obtaine_d directly from the doctor's office. To date, other drugs used to
treat opioid dependency - such as methadone - can only be administered in clinics.

1bis increased access for buprenorphine reflects a change in the level of urgency that the opioid
epidemic presents to the medical community- one that demands broadened patient access to opioid
dependency medication and other forms of treatment.
·
Buprenorphine isn't prescribed in isolation; ifs one component of a comprehensive recovery program
designed to address the patient's individual needs.
Buprenorphine alone has potential fo~ abuse and prescription _diversion due to its opio.i d effects.
However, formulations that contain a combination of buprenorphine and naloxone decrease the potential
for abuse because naloxone otherwise blocks a robust opioid effect and, further, will initiate withdrawal
symptoms if attempts are made to misuse it via injection.
When used properly, these buprenorphine-containing medications can both alleviate unpleasant opioid
withdrawal and decrease associated cravings.
·
These medications are also difficult to overdose on, due to the ceiling effect that buprenorphine has ( and
to the opioid antagonism of naloxone, in the combination formulations). Once you reach a .certain dose,
the effects plateau and dori't increase with higher do·ses.

Probuphine

In May 2016, the FDA approved, the first buprenorphine implant designed to treat opioid dependence.
Like methadone and naltrexone, Probuphine is designed to help individuals recover from an opioid
addiction by alleviating cravings and withdrawal symptoms without creating a euphoric high. By
stabilizing the patient and reducing the sometimes overwhelming cravings associated with opioid
addiction, the individual is better able to engage in treatment and therapy.
The Probuphine implant is made of four rods that are inserted into the upper arm. The rods administer
a continuous dose ofbuprenorphine into the bloodstream'for a treatment period of 6 months-ma.king it
a convenient alternative to the other forms of buprenorphine (daily pills and dissolvable·:films). The drug
is prescribed to patients who are currently stable on low-to-moderate doses ofbuprenorpbine.
Pro buphine is not recommended beyond two 6-month treatment periods (which would necessitate
sequential rod insertion into each arm).

This medication presents advantages over other maintenance medications like methadone. Specifically:
Probuphine does not require daily administration, as it releases a low dose of the drug on a continuous
basis.
·
·
·
.
Probuphine cannot be abused if the implant stays in place.

NOTE: If the implant does get expelled or removed, there is potential for either accidental exposure or
intentional misuse.
Methadone

Methadone is a full opioid agonist, which means that it produces simil~ effects to other opioids.
However, because it is longer-acting than drugs like heroin, the effects are milder and shouldn't
significantly impact the individual's ability to function.
Methadone is used to alleviate withdrawal symptoms and drug cravings in those addicted to heroin or
·painkillers. In fact, one dose can prevent cravings and withdrawal for up to a·day and a half, according·
to the Center for Substance Abuse Treatment (CSA1). In order to prevent abuse, methadone is
administered in a clinic on a set schedule.
Despite its relatively mild effects (no extreme highs associated with it), those taking methadone would
likely still experience unpleasant withdrawal symptoms if methadone therapy were to suddenly stop, so
it's important to talk to your doctor if you want to.go off methadone.
Naloxone

Naloxone is an opioid antagonist, which means th.at it blocks the activity of opioids at the receptor sites
- potentially reversing or preventing life-threatening overdoses. A naloxone injection may be
administered in a medical emergency tq those who are experiencing an opioid overdose. As a potentially
life-saving intervention, both opioid users and family members should understand how naloxone works
'and how to use it in the event of an overdose.
Naloxone can come in automatic injection devices,_which are sometimes handed out as a harm reduction
measure in communities bit hard by heroin abuse. Automatic naloxone injection devices have voice
control and walk the injector through administration in a step-by-step·manner. If you're using opioids
and have been given a naloxone injection device, keep it on you at all times in the event of an
emergency.
It's essential to know the warning signs of an opioid overdose so that you can recognize an emergency
situation and administer naloxone, if accessible. The following are signs of an opioid overdose:

Tiny; constricted pupils.
Shallow breathing.
Severe drowsiness.

Loss of. consciousness.
Unresponsiveness.

Naltrexone
Naltrexone, which can come in an injectable or pill form, is used to treat patients who suffer from an
addiction to alcohol or opioids. The injectable ver~ion is called Vivitrol. It may be administered
intramuscularly, and therefore only requires monthly dosing. Oral dosing occurs once a day. Unlike
buprenorphine and methadone, nalirexone lacks potential for diversion and abuse.
Nalirexone works by blocking the opioid receptors. What this means is that if you take the drug and then
take alcohol or opioids, you won't experience the usual euphoria or "high" associated with those
/ substances. It may also decrease the general urge to use opioids or alcohol.
It's important to note that nalirexone decreases your tolerance to opioids, so· relapse can potentially be
dangerous if you return to taking the amount you once did. Overdose and fatal respiratory
depression may result.
Conversely, there ar-en't any risks associated with drinking while taking the appr9priate amo:unt of
naltrexone. When taken in excess, it can lead to severe liver damage, which is why patients should
follow their doctor's instructions -carefully. Within prescribed parameters, there aren't any specific
contramdications to using naltrexone concurrently with alcohol. Despite any overt effects to serve as a
deterrent to drinking however, it will still aid in decreasing drinking behaviors due to the lack of ·
euphoria e_xperienced. While naltrexone blocks the individual from experiencing fully the rewarding
effects of alcohol, it does not decrease the other intoxicating effects, such as impaired judgment and
coordination.

APPENDIXZ
List of materials available on the website for the
Task Force to Address the Opioid Crisis in the State

The following documents were posted as related resources on the website of the Task Force to
Address the Opioid Crisis in the State. If the identified links no longer work, documents may be
requested from the Office of Policy and Legal Analysis.
Related Documents:
•

•
•
•
•

Prescription Opioids the Top Contraband Item Intercepted at Maine Jails, Report
Finds https://bangordailynews.com/2017/07 /18/news/state/prescription-opioids-the-topcontraband-item-intercepted-at-maine-jails-repmi-finds/
Updated Spreadsheet on Proposed Opioid Legislation (as of 4/11/17)
http://www.maine.gov/legis/opla/OTFProposedOpioidLegislationMaine.pdf
"No Opioids, Please; A Growing Movement Lets Patients Refuse Prescriptions" - March
2017 (https://www.statnews.com/2017/03/19/opioid-prescription-refuse/)
"Recommendations of the Maine Opiate Collaborative", May 2016
(https://wwwl .maine.gov/ag/docs/20160513084630118.pdf)
"State Solutions to the Opioid Epidemic"; Webinar from the Council of State
Governments, 3/21/17
(https://www.youtube.com/watch?v=Nh4WRl e STY &feature=youtu.be)

April 11, 201 7 Presentations on Opioid Addiction and Treatment by MaineHealth to the Health
and Human Services Committee:
•
•
•
•

Dr. Silvia Comments to HHS Committee - April 11 2017
(http://www.maine.gov/legis/opla/OTFDr.SilviaHHSCommittee.pdf)
EMHS Slides (http://www.maine.gov/legis/opla/OTFEMHSslides.pdf)
.
HHSC Medical Basis (http://www.maine.gov/legis/opla/OTFHHSCMedica1Basis.pdf) · ·
Hub and Spoke Model (http://www.maine.gov/legis/opla/OTFHubandSpokeModel.pdf)

